<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://fazen.markets/zh/联盟洗衣q3净利增98</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:57:41.106Z</news:publication_date>
      <news:title>联盟洗衣Q3净利润飙升98%至6500万美元，上调EBITDA指引</news:title>
      <news:keywords>alliance-laundry, ALH-stock, commercial-laundry, earnings-report, adjusted-ebitda-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/alliance-laundry-beneficio-t3-98-65m-eleva-guia-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:57:41.105Z</news:publication_date>
      <news:title>Alliance Laundry dispara un 98% su beneficio neto del T3 hasta 65 M$ y eleva la guía de EBITDA</news:title>
      <news:keywords>alliance-laundry, ALH-stock, commercial-laundry, earnings-report, adjusted-ebitda-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/alliance-laundry-benefice-net-t3-98-pourcent-guide-ebitda-releve</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:57:41.105Z</news:publication_date>
      <news:title>Alliance Laundry : bénéfice net T3 +98% à 65 M$, guide EBITDA relevé</news:title>
      <news:keywords>alliance-laundry, ALH-stock, commercial-laundry, earnings-report, adjusted-ebitda-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/alliance-laundry-utile-q3-98percento-alza-guida-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:57:41.105Z</news:publication_date>
      <news:title>Alliance Laundry: utile Q3 +98% a 65 mln, alza guida EBITDA</news:title>
      <news:keywords>alliance-laundry, ALH-stock, commercial-laundry, earnings-report, adjusted-ebitda-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/alliance-laundry-q3-2026-net-income-ebitda-guidance-raise</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:57:41.105Z</news:publication_date>
      <news:title>Alliance Laundry Q3 Net Income Jumps 98% to $65M, Lifts EBITDA Guide</news:title>
      <news:keywords>alliance-laundry, ALH-stock, commercial-laundry, earnings-report, adjusted-ebitda-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/exagen-ingresos-t3-2026-crecen-7-por-ciento-perdida-neta-se-reduce</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:51:37.797Z</news:publication_date>
      <news:title>Exagen eleva sus ingresos del T3 un 7% a 18,4 M$ y reduce su pérdida neta</news:title>
      <news:keywords>exagen, xgn, autoimmune-diagnostics, avise-ctd, precision-medicine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/exagen第三季度营收增长净亏损收窄</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:51:37.797Z</news:publication_date>
      <news:title>Exagen第三季度营收增长7%至1840万美元，净亏损收窄</news:title>
      <news:keywords>exagen, xgn, autoimmune-diagnostics, avise-ctd, precision-medicine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/exagen-ricavi-q3-crescono-7-percento-perdita-netta-cala</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:51:37.796Z</news:publication_date>
      <news:title>Exagen: ricavi Q3 +7% a 18,4 mln, perdita netta in calo</news:title>
      <news:keywords>exagen, xgn, autoimmune-diagnostics, avise-ctd, precision-medicine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/exagen-chiffre-affaires-t3-progresse-7-pourcent-perte-nette-reduite</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:51:37.796Z</news:publication_date>
      <news:title>Exagen : le chiffre d&apos;affaires T3 progresse de 7% à 18,4 M$</news:title>
      <news:keywords>exagen, xgn, autoimmune-diagnostics, avise-ctd, precision-medicine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/exagen-q3-2026-revenue-18-4-million-net-loss-narrows</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:51:37.796Z</news:publication_date>
      <news:title>Exagen Q3 Revenue Rises 7% to $18.4M, Net Loss Narrows</news:title>
      <news:keywords>exagen, xgn, autoimmune-diagnostics, avise-ctd, precision-medicine</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/hive-digital-ricavi-q2-84-mln-gpu-ai-crescita-70</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:50:39.419Z</news:publication_date>
      <news:title>HIVE Digital: ricavi Q2 a 84,9 mln $, vendite GPU AI +70%</news:title>
      <news:keywords>hive-digital, bitcoin-mining, ai-gpu-cloud, data-center-infrastructure, q2-fy2027-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/hive数字q2营收ai-gpu</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:50:39.419Z</news:publication_date>
      <news:title>HIVE Digital第二季度营收达8490万美元，AI GPU销售额跃升70%</news:title>
      <news:keywords>hive-digital, bitcoin-mining, ai-gpu-cloud, data-center-infrastructure, q2-fy2027-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/hive-digital-ingresos-t2-ventas-gpu-ia-suben-70</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:50:39.419Z</news:publication_date>
      <news:title>HIVE Digital factura 84,9 M$ en el T2 con ventas de GPU para IA al alza del 70%</news:title>
      <news:keywords>hive-digital, bitcoin-mining, ai-gpu-cloud, data-center-infrastructure, q2-fy2027-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/hive-digital-revenus-t2-849-m-ventes-gpu-ia-70</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:50:39.419Z</news:publication_date>
      <news:title>HIVE Digital : revenus T2 à 84,9 M$ et ventes GPU IA +70%</news:title>
      <news:keywords>hive-digital, bitcoin-mining, ai-gpu-cloud, data-center-infrastructure, q2-fy2027-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/hive-digital-q2-fy2027-revenue-ai-gpu-cloud-arr</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:50:39.418Z</news:publication_date>
      <news:title>HIVE Digital Q2 Revenue Hits $84.9M as AI GPU Sales Jump 70%</news:title>
      <news:keywords>hive-digital, bitcoin-mining, ai-gpu-cloud, data-center-infrastructure, q2-fy2027-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/mastercraft净销售增123</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:44:31.121Z</news:publication_date>
      <news:title>MasterCraft 海洋产品并表推动净销售额飙升123%至1.54亿美元</news:title>
      <news:keywords>mastercraft-boat-holdings, mcft, marine-products, recreational-powerboats, transition-period-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/mastercraft-ventas-netas-123-marine-products-fusion</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:44:31.121Z</news:publication_date>
      <news:title>MasterCraft dispara sus ventas netas un 123% hasta 154 M$ por Marine Products</news:title>
      <news:keywords>mastercraft-boat-holdings, mcft, marine-products, recreational-powerboats, transition-period-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/mastercraft-ventes-nettes-123-pour-cent-produits-marins</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:44:31.120Z</news:publication_date>
      <news:title>MasterCraft : ventes nettes en hausse de 123 % à 154 M$</news:title>
      <news:keywords>mastercraft-boat-holdings, mcft, marine-products, recreational-powerboats, transition-period-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/mastercraft-vendite-nette-balcate-123percento-marine-products</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:44:31.120Z</news:publication_date>
      <news:title>Vendite nette MasterCraft balzano del 123% a 154 mln $ grazie a Marine Products</news:title>
      <news:keywords>mastercraft-boat-holdings, mcft, marine-products, recreational-powerboats, transition-period-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/mastercraft-boat-holdings-net-sales-jump-123-percent-marine-products</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:44:31.116Z</news:publication_date>
      <news:title>MasterCraft Net Sales Jump 123% to $154M on Marine Products</news:title>
      <news:keywords>mastercraft-boat-holdings, mcft, marine-products, recreational-powerboats, transition-period-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/janus亏损1330万下调2026指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:38:23.828Z</news:publication_date>
      <news:title>Janus International第三季度亏损1330万美元，下调2026年业绩指引</news:title>
      <news:keywords>janus-international, jbi-earnings, q3-2026-results, self-storage-equities, guidance-cut</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/janus-international-perdidas-t3-2026-recorte-guidance-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:38:23.826Z</news:publication_date>
      <news:title>Janus International registra pérdidas de 13,3 M$ en el T3 y recorta guidance 2026</news:title>
      <news:keywords>janus-international, jbi-earnings, q3-2026-results, self-storage-equities, guidance-cut</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/janus-international-perte-t3-reduction-previsions-2026-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:38:23.826Z</news:publication_date>
      <news:title>Janus International enregistre une perte de 13,3 M$ au T3 et réduit ses prévisions 2026</news:title>
      <news:keywords>janus-international, jbi-earnings, q3-2026-results, self-storage-equities, guidance-cut</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/janus-international-perdita-q3-taglia-guidance-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:38:23.825Z</news:publication_date>
      <news:title>Janus International registra una perdita di 13,3 mln nel Q3, taglia la guidance 2026</news:title>
      <news:keywords>janus-international, jbi-earnings, q3-2026-results, self-storage-equities, guidance-cut</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/janus-international-q3-2026-net-loss-guidance-cut-jbi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:38:23.825Z</news:publication_date>
      <news:title>Janus International Posts $13.3M Q3 Loss, Cuts 2026 Guidance</news:title>
      <news:keywords>janus-international, jbi-earnings, q3-2026-results, self-storage-equities, guidance-cut</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/harvard-bioscience-ingresos-t3-suben-8-recorta-prevision-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:22.849Z</news:publication_date>
      <news:title>Harvard Bioscience: ingresos del T3 suben 8% a 22,2 M$, recorta previsión de EBITDA</news:title>
      <news:keywords>harvard-bioscience, hbio, life-science-tools, earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/哈佛生物科学q3下调ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:22.849Z</news:publication_date>
      <news:title>哈佛生物科学Q3营收增8%至2220万美元，下调EBITDA指引</news:title>
      <news:keywords>harvard-bioscience, hbio, life-science-tools, earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/harvard-bioscience-ca-t3-hausse-previsions-ebitda-reduites</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:22.849Z</news:publication_date>
      <news:title>Harvard Bioscience : CA T3 +8% à 22,2 M$, prévisions d&apos;EBITDA réduites</news:title>
      <news:keywords>harvard-bioscience, hbio, life-science-tools, earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/harvard-bioscience-q3-2026-revenue-growth-ebitda-guidance-cut</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:22.848Z</news:publication_date>
      <news:title>Harvard Bioscience Q3 Revenue Up 8% to $22.2M, Cuts EBITDA Outlook</news:title>
      <news:keywords>harvard-bioscience, hbio, life-science-tools, earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/harvard-bioscience-ricavi-q3-su-ebitda-ridotta-previsione</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:37:22.848Z</news:publication_date>
      <news:title>Harvard Bioscience: ricavi Q3 +8% a 22,2 mln, taglia EBITDA</news:title>
      <news:keywords>harvard-bioscience, hbio, life-science-tools, earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/autolus-aucatzyl-营收飙升</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:36:25.160Z</news:publication_date>
      <news:title>Autolus第三季度营收飙升95%，AUCATZYL突破4100万美元</news:title>
      <news:keywords>autolus-therapeutics, autl, aucatzyl, obe-cel, car-t-therapy, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/autolus-q3-ingresos-aucatzyl-suben-95-por-ciento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:36:25.160Z</news:publication_date>
      <news:title>Autolus Q3: ingresos suben 95% con AUCATZYL sobre $41M</news:title>
      <news:keywords>autolus-therapeutics, autl, aucatzyl, obe-cel, car-t-therapy, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/autolus-t3-chiffre-affaires-aucatzyl-bondit-95-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:36:25.160Z</news:publication_date>
      <news:title>Autolus T3 : le chiffre d&apos;affaires bondit de 95 %, AUCATZYL dépasse 41 M$</news:title>
      <news:keywords>autolus-therapeutics, autl, aucatzyl, obe-cel, car-t-therapy, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/autolus-therapeutics-q3-2026-aucatzyl-revenue-41-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:36:25.159Z</news:publication_date>
      <news:title>Autolus Q3 Revenue Jumps 95% as AUCATZYL Tops $41M</news:title>
      <news:keywords>autolus-therapeutics, autl, aucatzyl, obe-cel, car-t-therapy, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/autolus-ricavi-q3-2026-aucatzyl-crescita-95-guidance-150-mln</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:36:25.159Z</news:publication_date>
      <news:title>Autolus: ricavi Q3 +95%, AUCATZYL oltre 41 mln $</news:title>
      <news:keywords>autolus-therapeutics, autl, aucatzyl, obe-cel, car-t-therapy, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/cellectar-biosciences-q3-2026-loss-widens-iopofosine-waldenstrom-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:35:27.372Z</news:publication_date>
      <news:title>Cellectar Q3 Loss Widens to $8M as WM Trial Nears 2027</news:title>
      <news:keywords>cellectar-biosciences, clrb, iopofosine-i-131, waldenstrom-macroglobulinemia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/cellectar第三季度亏损扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:35:27.372Z</news:publication_date>
      <news:title>Cellectar第三季度亏损扩大至800万美元，WM试验临近2027年</news:title>
      <news:keywords>cellectar-biosciences, clrb, iopofosine-i-131, waldenstrom-macroglobulinemia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/cellectar-perdidas-t3-2026-ensayo-waldenstrom-nda-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:35:27.372Z</news:publication_date>
      <news:title>Cellectar amplía pérdidas del T3 a 8 M$ con ensayo WM hacia 2027</news:title>
      <news:keywords>cellectar-biosciences, clrb, iopofosine-i-131, waldenstrom-macroglobulinemia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/cellectar-perte-t3-2026-elargie-essai-wm-nda-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:35:27.372Z</news:publication_date>
      <news:title>Cellectar : perte T3 élargie à 8 M$, essai WM vers 2027</news:title>
      <news:keywords>cellectar-biosciences, clrb, iopofosine-i-131, waldenstrom-macroglobulinemia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cellectar-perdita-q3-8-milioni-trial-wm-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:35:27.372Z</news:publication_date>
      <news:title>Cellectar: perdita Q3 a 8 mln, trial WM verso 2027</news:title>
      <news:keywords>cellectar-biosciences, clrb, iopofosine-i-131, waldenstrom-macroglobulinemia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/pyxus债券置换股票浮动利率</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:34:29.095Z</news:publication_date>
      <news:title>Pyxus以股票及浮动利率票据置换8.50%债券</news:title>
      <news:keywords>pyxus-international, senior-secured-notes, exchange-offer, consent-solicitation, distressed-debt</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/pyxus-canjea-bonos-850-por-acciones-y-papel-flotante</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:34:29.094Z</news:publication_date>
      <news:title>Pyxus canjea bonos del 8,50% por acciones y papel a tipo flotante</news:title>
      <news:keywords>pyxus-international, senior-secured-notes, exchange-offer, consent-solicitation, distressed-debt</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/pyxus-echange-obligations-8-50-actions-taux-variable</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:34:29.094Z</news:publication_date>
      <news:title>Pyxus échange ses obligations 8,50% contre actions et titres à taux variable</news:title>
      <news:keywords>pyxus-international, senior-secured-notes, exchange-offer, consent-solicitation, distressed-debt</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/pyxus-scambio-note-8-50-azioni-tasso-variabile</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:34:29.081Z</news:publication_date>
      <news:title>Pyxus scambia le note 8,50% con azioni e carta a tasso variabile</news:title>
      <news:keywords>pyxus-international, senior-secured-notes, exchange-offer, consent-solicitation, distressed-debt</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/pyxus-exchange-offer-8-50-senior-secured-notes-2027-consent-solicitation</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:34:29.081Z</news:publication_date>
      <news:title>Pyxus Swaps 8.50% Notes for Equity, Floating Rate Paper</news:title>
      <news:keywords>pyxus-international, senior-secured-notes, exchange-offer, consent-solicitation, distressed-debt</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/vireo-growth第三季度营收因并购激增177-至2-537亿美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:33:33.113Z</news:publication_date>
      <news:title>Vireo Growth第三季度营收因并购激增177%至2.537亿美元</news:title>
      <news:keywords>vireo-growth, cannabis-ma, vireo-earnings, planet-13-merger, adjusted-ebitda-margin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/vireo-growth-ingresos-t3-177-por-ciento-fusiones-margen-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:33:33.113Z</news:publication_date>
      <news:title>Vireo Growth dispara sus ingresos del T3 un 177% hasta 253,7 M$ por fusiones</news:title>
      <news:keywords>vireo-growth, cannabis-ma, vireo-earnings, planet-13-merger, adjusted-ebitda-margin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/vireo-growth-ricavi-q3-2026-crescita-acquisizioni-margini</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:33:33.112Z</news:publication_date>
      <news:title>Vireo Growth: ricavi Q3 +177% a 253,7 mln $ per M&amp;A</news:title>
      <news:keywords>vireo-growth, cannabis-ma, vireo-earnings, planet-13-merger, adjusted-ebitda-margin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/vireo-growth-chiffre-affaires-t3-bondit-177-pourcent-253-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:33:33.112Z</news:publication_date>
      <news:title>Vireo Growth : le chiffre d&apos;affaires T3 bondit de 177% à 253,7 M$</news:title>
      <news:keywords>vireo-growth, cannabis-ma, vireo-earnings, planet-13-merger, adjusted-ebitda-margin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/vireo-growth-q3-2026-revenue-253-7-million-acquisitions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:33:33.112Z</news:publication_date>
      <news:title>Vireo Growth Q3 Revenue Jumps 177% to $253.7M on M&amp;A</news:title>
      <news:keywords>vireo-growth, cannabis-ma, vireo-earnings, planet-13-merger, adjusted-ebitda-margin</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/kustom-entertainment-ingresos-t3-suben-57-venta-unidad-video</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:32:29.665Z</news:publication_date>
      <news:title>Kustom Entertainment: ingresos del T3 suben 57% a 2,7 M$</news:title>
      <news:keywords>kustom-entertainment, KUST, ticketing-stocks, live-entertainment, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/kustom娱乐q3营收增57</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:32:29.665Z</news:publication_date>
      <news:title>Kustom娱乐第三季度营收跃升57%至270万美元</news:title>
      <news:keywords>kustom-entertainment, KUST, ticketing-stocks, live-entertainment, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/kustom-entertainment-chiffre-affaires-t3-bondit-57-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:32:29.665Z</news:publication_date>
      <news:title>Kustom Entertainment : le chiffre d&apos;affaires du T3 bondit de 57 % à 2,7 M$</news:title>
      <news:keywords>kustom-entertainment, KUST, ticketing-stocks, live-entertainment, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/kustom-entertainment-ricavi-q3-57-percento-2-7-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:32:29.664Z</news:publication_date>
      <news:title>Kustom Entertainment: ricavi Q3 +57% a 2,7 mln $</news:title>
      <news:keywords>kustom-entertainment, KUST, ticketing-stocks, live-entertainment, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/kustom-entertainment-q3-2026-revenue-57-percent-net-income-2-3-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:32:29.664Z</news:publication_date>
      <news:title>Kustom Entertainment Q3 Revenue Jumps 57% to $2.7M</news:title>
      <news:keywords>kustom-entertainment, KUST, ticketing-stocks, live-entertainment, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/chicago-atlantic-refi-utili-q3-049-dollari-merger-lien</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:26:26.384Z</news:publication_date>
      <news:title>Chicago Atlantic REFI: utili Q3 a 0,49 dollari, merger in arrivo</news:title>
      <news:keywords>refi, chicago-atlantic, mortgage-reit, cannabis-lending, lien-merger</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/refi三季度收益跌至0-49美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:26:26.384Z</news:publication_date>
      <news:title>芝加哥大西洋REFI第三季度收益降至每股0.49美元，合并临近</news:title>
      <news:keywords>refi, chicago-atlantic, mortgage-reit, cannabis-lending, lien-merger</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/chicago-atlantic-refi-resultados-q3-caida-beneficios-fusion-lien</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:26:26.384Z</news:publication_date>
      <news:title>Chicago Atlantic REFI cae a 0,49 dólares en el Q3 con la fusión en el horizonte</news:title>
      <news:keywords>refi, chicago-atlantic, mortgage-reit, cannabis-lending, lien-merger</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/chicago-atlantic-refi-benefices-t3-049-dollar-fusion-lien</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:26:26.384Z</news:publication_date>
      <news:title>Chicago Atlantic REFI : bénéfices T3 à 0,49 $, fusion en vue</news:title>
      <news:keywords>refi, chicago-atlantic, mortgage-reit, cannabis-lending, lien-merger</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/chicago-atlantic-refi-q3-2026-earnings-merger-lien</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:26:26.384Z</news:publication_date>
      <news:title>Chicago Atlantic REFI Q3 Earnings Fall to $0.49 as Merger Looms</news:title>
      <news:keywords>refi, chicago-atlantic, mortgage-reit, cannabis-lending, lien-merger</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/liquidia-uthr和解致亏损</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:25:23.973Z</news:publication_date>
      <news:title>Liquidia第三季度销售额达2.227亿美元，与UTHR和解致亏损扩大</news:title>
      <news:keywords>liquidia, lqda, yutrepia, united-therapeutics, pulmonary-arterial-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/liquidia-ventas-t3-2227-m-acuerdo-united-therapeutics-perdidas</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:25:23.973Z</news:publication_date>
      <news:title>Ventas de Liquidia en el T3 alcanzan 222,7 M$ mientras el acuerdo con UTHR eleva las pérdidas</news:title>
      <news:keywords>liquidia, lqda, yutrepia, united-therapeutics, pulmonary-arterial-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/liquidia-ventes-t3-2227-m-perte-reglement-united-therapeutics</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:25:23.972Z</news:publication_date>
      <news:title>Liquidia : ventes T3 de 222,7 M$ et perte creusée par UTHR</news:title>
      <news:keywords>liquidia, lqda, yutrepia, united-therapeutics, pulmonary-arterial-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/liquidia-vendite-q3-222-mln-perdita-accordo-united-therapeutics</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:25:23.972Z</news:publication_date>
      <news:title>Vendite Liquidia Q3 a 222,7 mln $, perdita per accordo UTHR</news:title>
      <news:keywords>liquidia, lqda, yutrepia, united-therapeutics, pulmonary-arterial-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/liquidia-q3-2026-yutrepia-sales-united-therapeutics-settlement</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:25:23.972Z</news:publication_date>
      <news:title>Liquidia Q3 Sales Hit $222.7M as UTHR Settlement Lifts Loss</news:title>
      <news:keywords>liquidia, lqda, yutrepia, united-therapeutics, pulmonary-arterial-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/d-wave-rpo激增1221</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:24:19.946Z</news:publication_date>
      <news:title>D-Wave第三季度营收增长21%，RPO激增1,221%</news:title>
      <news:keywords>d-wave, qbts, quantum-computing, earnings, qbts-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/d-wave-revenus-t3-2026-rpo-1221-chips-quantique</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:24:19.945Z</news:publication_date>
      <news:title>D-Wave : revenus T3 +21%, RPO +1 221%</news:title>
      <news:keywords>d-wave, qbts, quantum-computing, earnings, qbts-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/d-wave-q3-ingresos-suben-21-rpo-salta-1221</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:24:19.945Z</news:publication_date>
      <news:title>D-Wave Q3 ingresos suben 21% y RPO salta 1.221%</news:title>
      <news:keywords>d-wave, qbts, quantum-computing, earnings, qbts-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/d-wave-ricavi-q3-2026-rpo-balza-1221-percento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:24:19.944Z</news:publication_date>
      <news:title>D-Wave: ricavi Q3 +21%, RPO balza del 1.221%</news:title>
      <news:keywords>d-wave, qbts, quantum-computing, earnings, qbts-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/d-wave-qbts-q3-2026-revenue-rpo-bookings-results</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:24:19.944Z</news:publication_date>
      <news:title>D-Wave Q3 Revenue Rises 21% as RPO Jumps 1,221%</news:title>
      <news:keywords>d-wave, qbts, quantum-computing, earnings, qbts-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/opus-genetics-perdita-q3-2026-costi-terapia-genica</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:23:16.820Z</news:publication_date>
      <news:title>Opus Genetics: perdita Q3 sale a 46,5 mln $, costi terapia genica</news:title>
      <news:keywords>opus-genetics, gene-therapy, ird-pipeline, biotech-earnings, nasdaq-ird</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/opus-genetics基因治疗亏损扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:23:16.820Z</news:publication_date>
      <news:title>Opus Genetics第三季度亏损扩大至4650万美元，基因治疗成本飙升</news:title>
      <news:keywords>opus-genetics, gene-therapy, ird-pipeline, biotech-earnings, nasdaq-ird</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/opus-genetics-perdidas-t3-2026-terapia-genica-costes</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:23:16.820Z</news:publication_date>
      <news:title>Opus Genetics amplía pérdidas a 46,5 M$ en el T3 por costes de terapia génica</news:title>
      <news:keywords>opus-genetics, gene-therapy, ird-pipeline, biotech-earnings, nasdaq-ird</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/opus-genetics-perte-t3-2026-therapie-genique-couts-recherche</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:23:16.820Z</news:publication_date>
      <news:title>Opus Genetics : perte T3 élargie à 46,5 M$</news:title>
      <news:keywords>opus-genetics, gene-therapy, ird-pipeline, biotech-earnings, nasdaq-ird</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/opus-genetics-q3-2026-net-loss-46-5-million-gene-therapy-pipeline</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:23:16.819Z</news:publication_date>
      <news:title>Opus Genetics Q3 Loss Widens to $46.5M as Gene Therapy Costs Jump</news:title>
      <news:keywords>opus-genetics, gene-therapy, ird-pipeline, biotech-earnings, nasdaq-ird</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/hemab-dosifica-primer-paciente-ensayo-fase-1-hmb-003</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:22:08.646Z</news:publication_date>
      <news:title>Hemab dosifica al primer paciente en el ensayo Fase 1 de HMB-003</news:title>
      <news:keywords>hemab-therapeutics, coag, sutacimig, glanzmann-thrombasthenia, heavy-menstrual-bleeding</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/hemab启动hmb-003一期试验</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:22:08.646Z</news:publication_date>
      <news:title>Hemab启动HMB-003一期试验首例给药</news:title>
      <news:keywords>hemab-therapeutics, coag, sutacimig, glanzmann-thrombasthenia, heavy-menstrual-bleeding</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/hemab-premier-patient-essai-hmb-003-phase-1</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:22:08.646Z</news:publication_date>
      <news:title>Hemab dose le premier patient dans l&apos;essai HMB-003 de phase 1</news:title>
      <news:keywords>hemab-therapeutics, coag, sutacimig, glanzmann-thrombasthenia, heavy-menstrual-bleeding</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/hemab-primo-paziente-fase-1-hmb-003-sutacimig-glanzmann</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:22:08.645Z</news:publication_date>
      <news:title>Hemab dosa il primo paziente nello studio di Fase 1 su HMB-003</news:title>
      <news:keywords>hemab-therapeutics, coag, sutacimig, glanzmann-thrombasthenia, heavy-menstrual-bleeding</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/hemab-therapeutics-q3-2026-results-hmb-003-phase-1-solara</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:22:08.644Z</news:publication_date>
      <news:title>Hemab Doses First Patient in HMB-003 Phase 1 Trial</news:title>
      <news:keywords>hemab-therapeutics, coag, sutacimig, glanzmann-thrombasthenia, heavy-menstrual-bleeding</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/lensar-q3-2026-ally-225</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:21:04.431Z</news:publication_date>
      <news:title>LENSAR 2026年第三季度：经常性收入跃升17%，ALLY装机量达225台</news:title>
      <news:keywords>lensar, lnsr, cataract-laser, medical-device-earnings, recurring-revenue</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/lensar-q3-2026-ingresos-recurrentes-suben-17-base-ally-225</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:21:04.431Z</news:publication_date>
      <news:title>LENSAR Q3 2026: ingresos recurrentes suben 17% y base ALLY llega a 225</news:title>
      <news:keywords>lensar, lnsr, cataract-laser, medical-device-earnings, recurring-revenue</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/lensar-q3-2026-ricavi-ricorrenti-crescita-base-ally</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:21:04.430Z</news:publication_date>
      <news:title>LENSAR Q3 2026: ricavi ricorrenti +17%, base ALLY a 225</news:title>
      <news:keywords>lensar, lnsr, cataract-laser, medical-device-earnings, recurring-revenue</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/lensar-t3-2026-revenus-recurrents-17-base-ally-225</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:21:04.430Z</news:publication_date>
      <news:title>LENSAR T3 2026 : revenus récurrents +17%, base ALLY à 225</news:title>
      <news:keywords>lensar, lnsr, cataract-laser, medical-device-earnings, recurring-revenue</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/lensar-q3-2026-recurring-revenue-jumps-ally-installed-base-225</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:21:04.430Z</news:publication_date>
      <news:title>LENSAR Q3 2026: Recurring Revenue Jumps 17% as ALLY Base Hits 225</news:title>
      <news:keywords>lensar, lnsr, cataract-laser, medical-device-earnings, recurring-revenue</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/scholar-rock-vende-prv-205-milioni-lancio-isembild</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:20:01.267Z</news:publication_date>
      <news:title>Scholar Rock vende PRV per 205 mln $ mentre lancia ISEMBYLD</news:title>
      <news:keywords>scholar-rock, srkk, apitegromab, isembyld, priority-review-voucher, sma-therapy, biopharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/scholar-rock出售prv</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:20:01.267Z</news:publication_date>
      <news:title>Scholar Rock以2.05亿美元出售PRV，ISEMBYLD上市</news:title>
      <news:keywords>scholar-rock, srkk, apitegromab, isembyld, priority-review-voucher, sma-therapy, biopharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/scholar-rock-vende-prv-205-millones-lanzamiento-isemb-yld</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:20:01.267Z</news:publication_date>
      <news:title>Scholar Rock vende su PRV por 205 M$ mientras se lanza ISEMBYLD</news:title>
      <news:keywords>scholar-rock, srkk, apitegromab, isembyld, priority-review-voucher, sma-therapy, biopharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/scholar-rock-vend-prv-205-millions-lancement-isemb-yld</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:20:01.267Z</news:publication_date>
      <news:title>Scholar Rock vend son PRV pour 205 M$ au lancement d&apos;ISEMBYLD</news:title>
      <news:keywords>scholar-rock, srkk, apitegromab, isembyld, priority-review-voucher, sma-therapy, biopharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/scholar-rock-prv-sale-205m-isemb-yld-sma-launch</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:20:01.267Z</news:publication_date>
      <news:title>Scholar Rock Sells PRV for $205M as ISEMBYLD Launches</news:title>
      <news:keywords>scholar-rock, srkk, apitegromab, isembyld, priority-review-voucher, sma-therapy, biopharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/calcimedica-reduce-perdida-t3-2026-caja-138-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:18:55.738Z</news:publication_date>
      <news:title>CalciMedica reduce pérdida del T3 a 1,7M$ con 13,8M$ en caja</news:title>
      <news:keywords>calcimedica, calc-stock, biotech-earnings, crac-channel-inhibitor, pulmonary-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/calcimedica第三季度亏损收窄</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:18:55.738Z</news:publication_date>
      <news:title>CalciMedica第三季度亏损收窄至170万美元，现金1380万美元</news:title>
      <news:keywords>calcimedica, calc-stock, biotech-earnings, crac-channel-inhibitor, pulmonary-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/calcimedica-perte-t3-reduite-tresorerie-pipeline-clinique</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:18:55.737Z</news:publication_date>
      <news:title>CalciMedica réduit sa perte au T3 à 1,7 M$ avec 13,8 M$ de trésorerie</news:title>
      <news:keywords>calcimedica, calc-stock, biotech-earnings, crac-channel-inhibitor, pulmonary-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/calcimedica-perdita-q3-ridotta-liquidita-catalizzatori-clinici-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:18:55.737Z</news:publication_date>
      <news:title>CalciMedica: perdita Q3 ridotta a 1,7 mln su 13,8 mln di liquidità</news:title>
      <news:keywords>calcimedica, calc-stock, biotech-earnings, crac-channel-inhibitor, pulmonary-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/calcimedica-q3-2026-financial-results-cash-runway</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:18:55.737Z</news:publication_date>
      <news:title>CalciMedica Q3 Loss Narrows to $1.7M on $13.8M Cash</news:title>
      <news:keywords>calcimedica, calc-stock, biotech-earnings, crac-channel-inhibitor, pulmonary-hypertension</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/humacyte第三季度营收翻倍</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:12:49.380Z</news:publication_date>
      <news:title>Humacyte第三季度营收翻倍，Symvess销售额达100万美元</news:title>
      <news:keywords>humacyte, HUMA, symvess, atev-dialysis-access, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/humacyte-duplica-ingresos-t3-symvess-1-millones-sbla-dialisis</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:12:49.380Z</news:publication_date>
      <news:title>Humacyte duplica ingresos en el T3 con Symvess en 1 M$</news:title>
      <news:keywords>humacyte, HUMA, symvess, atev-dialysis-access, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/humacyte-chiffre-affaires-t3-double-symvess-1-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:12:49.379Z</news:publication_date>
      <news:title>Humacyte : le chiffre d&apos;affaires T3 double, Symvess à 1 M$</news:title>
      <news:keywords>humacyte, HUMA, symvess, atev-dialysis-access, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/humacyte-ricavi-q3-raddoppiano-symvess-1-milione</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:12:49.378Z</news:publication_date>
      <news:title>Humacyte: ricavi Q3 raddoppiano, Symvess a 1 mln $</news:title>
      <news:keywords>humacyte, HUMA, symvess, atev-dialysis-access, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/humacyte-q3-2026-symvess-revenue-doubles-atev-dialysis-sbla</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:12:49.378Z</news:publication_date>
      <news:title>Humacyte Q3 Revenue Doubles as Symvess Hits $1M</news:title>
      <news:keywords>humacyte, HUMA, symvess, atev-dialysis-access, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/908devices三季度营收增35</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:11:47.344Z</news:publication_date>
      <news:title>908 Devices第三季度营收跃升35%至1900万美元，上调2026年展望</news:title>
      <news:keywords>908-devices, mass-stock, q3-2026-earnings, handheld-chemical-detection, small-cap-growth</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/908-devices-ingresos-t3-2026-crecimiento-prevision</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:11:47.343Z</news:publication_date>
      <news:title>908 Devices eleva un 35% sus ingresos del T3 a 19 M$ y mejora la previsión para 2026</news:title>
      <news:keywords>908-devices, mass-stock, q3-2026-earnings, handheld-chemical-detection, small-cap-growth</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/908-devices-chiffre-affaires-t3-hausse-previsions-2026-relevees</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:11:47.343Z</news:publication_date>
      <news:title>908 Devices : chiffre d&apos;affaires T3 en hausse de 35 % à 19 M$, prévisions 2026 relevées</news:title>
      <news:keywords>908-devices, mass-stock, q3-2026-earnings, handheld-chemical-detection, small-cap-growth</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/908-devices-ricavi-q3-2026-crescita-35-alza-outlook</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:11:47.342Z</news:publication_date>
      <news:title>908 Devices: ricavi Q3 +35% a 19 mln $, alza outlook 2026</news:title>
      <news:keywords>908-devices, mass-stock, q3-2026-earnings, handheld-chemical-detection, small-cap-growth</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/908-devices-q3-2026-revenue-19m-raises-outlook-mass</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:11:47.342Z</news:publication_date>
      <news:title>908 Devices Q3 Revenue Jumps 35% to $19M, Raises 2026 Outlook</news:title>
      <news:keywords>908-devices, mass-stock, q3-2026-earnings, handheld-chemical-detection, small-cap-growth</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/olema-olma亏损现金opera-01</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:10:44.615Z</news:publication_date>
      <news:title>Olema Oncology第三季度亏损7360万美元，现金降至4.138亿美元</news:title>
      <news:keywords>olema-oncology, olma-stock, palazestrant, opera-01-trial, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/olema-oncology-perdidas-t3-2026-caja-opera-01</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:10:44.615Z</news:publication_date>
      <news:title>Olema Oncology registra pérdidas de 73,6 M$ en el T3 y su caja baja a 413,8 M$</news:title>
      <news:keywords>olema-oncology, olma-stock, palazestrant, opera-01-trial, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/olema-oncology-perte-t3-tresorerie-opera-01-biotech</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:10:44.614Z</news:publication_date>
      <news:title>Olema Oncology : perte de 73,6 M$ au T3, trésorerie à 413,8 M$</news:title>
      <news:keywords>olema-oncology, olma-stock, palazestrant, opera-01-trial, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/olema-oncology-perdita-q3-2026-liquidita-opera-01</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:10:44.614Z</news:publication_date>
      <news:title>Olema Oncology: perdita di 73,6 mln nel Q3, liquidità a 413,8 mln</news:title>
      <news:keywords>olema-oncology, olma-stock, palazestrant, opera-01-trial, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/olema-oncology-q3-2026-net-loss-cash-413-8-million-opera-01</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:10:44.614Z</news:publication_date>
      <news:title>Olema Oncology Posts $73.6M Q3 Loss, Cash Falls to $413.8M</news:title>
      <news:keywords>olema-oncology, olma-stock, palazestrant, opera-01-trial, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/upstream-bio亏损收窄现金至2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:09:39.632Z</news:publication_date>
      <news:title>Upstream Bio第三季度亏损收窄至4120万美元，现金可支撑至2027年</news:title>
      <news:keywords>upstream-bio, verekitug, biotech-earnings, tslp-inhibitor, clinical-stage-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/upstream-bio-reduce-perdidas-q3-caja-hasta-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:09:39.632Z</news:publication_date>
      <news:title>Upstream Bio reduce pérdidas del Q3 a 41,2 M$ y caja hasta 2027</news:title>
      <news:keywords>upstream-bio, verekitug, biotech-earnings, tslp-inhibitor, clinical-stage-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/upstream-bio-perte-t3-2026-tresorerie-2027-essais-phase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:09:39.631Z</news:publication_date>
      <news:title>Upstream Bio réduit sa perte au T3 à 41,2 M$, trésorerie jusqu&apos;en 2027</news:title>
      <news:keywords>upstream-bio, verekitug, biotech-earnings, tslp-inhibitor, clinical-stage-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/upstream-bio-perdita-q3-2026-cassa-fino-2027-verekitug-fase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:09:39.631Z</news:publication_date>
      <news:title>Upstream Bio riduce la perdita Q3 a 41,2 mln, cassa fino al 2027</news:title>
      <news:keywords>upstream-bio, verekitug, biotech-earnings, tslp-inhibitor, clinical-stage-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/upstream-bio-q3-2026-financial-results-verekitug-phase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:09:39.631Z</news:publication_date>
      <news:title>Upstream Bio Narrows Q3 Loss to $41.2M, Cash Runs to 2027</news:title>
      <news:keywords>upstream-bio, verekitug, biotech-earnings, tslp-inhibitor, clinical-stage-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/palladyne-ai营收飙升895</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:08:40.609Z</news:publication_date>
      <news:title>Palladyne AI营收飙升895%至860万美元，上调2026年指引</news:title>
      <news:keywords>palladyne-ai, pdyn, defense-tech, autonomous-drones, earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/palladyne-ai-ingresos-895-por-ciento-eleva-guia-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:08:40.609Z</news:publication_date>
      <news:title>Palladyne AI dispara sus ingresos un 895% hasta 8,6 M$ y eleva la guía 2026</news:title>
      <news:keywords>palladyne-ai, pdyn, defense-tech, autonomous-drones, earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/palladyne-ai-chiffre-affaires-895-pourcent-releve-objectifs-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:08:40.609Z</news:publication_date>
      <news:title>Palladyne AI : chiffre d&apos;affaires en hausse de 895% à 8,6 M$, objectifs 2026 relevés</news:title>
      <news:keywords>palladyne-ai, pdyn, defense-tech, autonomous-drones, earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/palladyne-ai-ricavi-895-8-6-mln-alza-guidance-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:08:40.608Z</news:publication_date>
      <news:title>Palladyne AI: ricavi +895% a 8,6 mln, alza guidance 2026</news:title>
      <news:keywords>palladyne-ai, pdyn, defense-tech, autonomous-drones, earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/palladyne-ai-q3-2026-revenue-895-percent-raises-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:08:40.608Z</news:publication_date>
      <news:title>Palladyne AI Revenue Jumps 895% to $8.6M, Raises 2026 Guidance</news:title>
      <news:keywords>palladyne-ai, pdyn, defense-tech, autonomous-drones, earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/cwco第三季度营收下滑</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:02:29.744Z</news:publication_date>
      <news:title>Consolidated Water第三季度营收下降11.9%至3090万美元</news:title>
      <news:keywords>consolidated-water, cwco, water-utilities, q3-2026-earnings, desalination</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/consolidated-water-q3-ingresos-caen-11-9-a-30-9-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:02:29.744Z</news:publication_date>
      <news:title>Consolidated Water Q3 ingresos caen 11,9% a 30,9 M$</news:title>
      <news:keywords>consolidated-water, cwco, water-utilities, q3-2026-earnings, desalination</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/consolidated-water-t3-chiffre-affaires-baisse-benefices-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:02:29.744Z</news:publication_date>
      <news:title>Consolidated Water T3 : chiffre d&apos;affaires -11,9% à 30,9 M$</news:title>
      <news:keywords>consolidated-water, cwco, water-utilities, q3-2026-earnings, desalination</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/consolidated-water-q3-2026-revenue-falls-11-9-percent-30-9-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:02:29.742Z</news:publication_date>
      <news:title>Consolidated Water Q3 Revenue Falls 11.9% to $30.9M</news:title>
      <news:keywords>consolidated-water, cwco, water-utilities, q3-2026-earnings, desalination</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/consolidated-water-ricavi-q3-calo-11-9-eps-dimezzato</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:02:29.742Z</news:publication_date>
      <news:title>Consolidated Water, ricavi Q3 -11,9% a 30,9 mln $</news:title>
      <news:keywords>consolidated-water, cwco, water-utilities, q3-2026-earnings, desalination</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/protalix-plx-elfabrio-指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:01:25.758Z</news:publication_date>
      <news:title>Protalix第三季度营收达2190万美元，重申2026年7800万至8300万美元指引</news:title>
      <news:keywords>protalix-biotherapeutics, plx-stock, biotech-earnings, elfabrio, prx-115-gout</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/protalix-ricavi-q3-2026-guidance-elfabrio-prx-115</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:01:25.758Z</news:publication_date>
      <news:title>Protalix: ricavi Q3 a 21,9 mln, conferma guidance 2026 di 78-83 mln</news:title>
      <news:keywords>protalix-biotherapeutics, plx-stock, biotech-earnings, elfabrio, prx-115-gout</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/protalix-biotherapeutics-q3-2026-revenue-2026-guidance-plx</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:01:25.758Z</news:publication_date>
      <news:title>Protalix Q3 Revenue Hits $21.9M, Reaffirms $78M-$83M 2026 Guidance</news:title>
      <news:keywords>protalix-biotherapeutics, plx-stock, biotech-earnings, elfabrio, prx-115-gout</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/protalix-revenus-t3-2026-objectif-confirme-elfabrio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:01:25.758Z</news:publication_date>
      <news:title>Protalix : revenus T3 de 21,9 M$, objectif 2026 de 78-83 M$ confirmé</news:title>
      <news:keywords>protalix-biotherapeutics, plx-stock, biotech-earnings, elfabrio, prx-115-gout</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/protalix-q3-ingresos-21-9m-reafirma-guia-78-83m-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T12:01:25.758Z</news:publication_date>
      <news:title>Protalix Q3 ingresos 21,9M$, reafirma guía 78-83M$ 2026</news:title>
      <news:keywords>protalix-biotherapeutics, plx-stock, biotech-earnings, elfabrio, prx-115-gout</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/sally-beauty第四季度每股收益跃升22</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:55:17.451Z</news:publication_date>
      <news:title>Sally Beauty第四季度每股收益跃升22%，2027财年指引定为2.20-2.30美元</news:title>
      <news:keywords>sally-beauty-holdings, sbh-earnings, consumer-staples-retail, beauty-retail, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/sally-beauty-bpa-t4-hausse-previsions-fy27-benefice-par-action</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:55:17.450Z</news:publication_date>
      <news:title>Sally Beauty : BPA T4 en hausse de 22%, prévisions FY27 à 2,20-2,30 $</news:title>
      <news:keywords>sally-beauty-holdings, sbh-earnings, consumer-staples-retail, beauty-retail, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/sally-beauty-eps-q4-crescita-guidance-fy27-margini</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:55:17.450Z</news:publication_date>
      <news:title>Sally Beauty: EPS Q4 +22%, guidance FY27 a 2,20-2,30 $</news:title>
      <news:keywords>sally-beauty-holdings, sbh-earnings, consumer-staples-retail, beauty-retail, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/sally-beauty-bpa-q4-sube-22-guia-ejercicio-27-220-230-dolares</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:55:17.450Z</news:publication_date>
      <news:title>Sally Beauty: BPA del cuarto trimestre sube un 22% y guía para el ejercicio 27 de 2,20-2,30 dólares</news:title>
      <news:keywords>sally-beauty-holdings, sbh-earnings, consumer-staples-retail, beauty-retail, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/sally-beauty-q4-2026-earnings-eps-guidance-sbh</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:55:17.449Z</news:publication_date>
      <news:title>Sally Beauty Q4 EPS Jumps 22%, FY27 Guidance Set at $2.20-$2.30</news:title>
      <news:keywords>sally-beauty-holdings, sbh-earnings, consumer-staples-retail, beauty-retail, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/upland-software-renuncia-dividendo-preferente-45-eleva-upld-comun</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:49:08.557Z</news:publication_date>
      <news:title>Upland Software renuncia al dividendo preferente del 4,5% y eleva UPLD común</news:title>
      <news:keywords>upland-software, upld, series-a-preferred, dividend-waiver, hggc, enterprise-software, preferred-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/upland-software-renonce-dividende-privilegie-45-soutient-upld</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:49:08.557Z</news:publication_date>
      <news:title>Upland Software renonce au dividende privilégié de 4,5 %, soutient l&apos;action UPLD</news:title>
      <news:keywords>upland-software, upld, series-a-preferred, dividend-waiver, hggc, enterprise-software, preferred-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/upland免除4-5-优先股息</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:49:08.557Z</news:publication_date>
      <news:title>Upland Software免除4.5%优先股股息，提振UPLD普通股</news:title>
      <news:keywords>upland-software, upld, series-a-preferred, dividend-waiver, hggc, enterprise-software, preferred-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/upland-software-rinuncia-dividendo-privilegiato-45-sostiene-upld</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:49:08.555Z</news:publication_date>
      <news:title>Upland Software rinuncia al dividendo privilegiato del 4,5%, sostiene UPLD</news:title>
      <news:keywords>upland-software, upld, series-a-preferred, dividend-waiver, hggc, enterprise-software, preferred-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/upland-software-waives-series-a-preferred-dividend-common-stockholders</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:49:08.555Z</news:publication_date>
      <news:title>Upland Software Waives 4.5% Preferred Dividend, Lifts UPLD Common</news:title>
      <news:keywords>upland-software, upld, series-a-preferred, dividend-waiver, hggc, enterprise-software, preferred-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/黑钻bdtx-cns-orr-86</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:48:05.669Z</news:publication_date>
      <news:title>黑钻公司CNS-ORR达86%，FDA支持关键性路径</news:title>
      <news:keywords>black-diamond-therapeutics, silevertinib, egfr-ncm-nsclc, fda-end-of-phase-2, bdtx-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/black-diamond-86-cns-orr-fda-respalda-via-pivotal-bdtx</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:48:05.669Z</news:publication_date>
      <news:title>Black Diamond logra 86% CNS-ORR y la FDA respalda vía pivotal</news:title>
      <news:keywords>black-diamond-therapeutics, silevertinib, egfr-ncm-nsclc, fda-end-of-phase-2, bdtx-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/black-diamond-silevertinib-cns-orr-fda-phase-3-metastases-cerebrales</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:48:05.668Z</news:publication_date>
      <news:title>Black Diamond atteint 86 % de CNS-ORR, la FDA soutient la voie pivotale</news:title>
      <news:keywords>black-diamond-therapeutics, silevertinib, egfr-ncm-nsclc, fda-end-of-phase-2, bdtx-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/black-diamond-silevertinib-cns-orr-86-fda-approvazione-accelerata</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:48:05.668Z</news:publication_date>
      <news:title>Black Diamond: CNS-ORR all&apos;86%, la FDA approva il percorso pivotale</news:title>
      <news:keywords>black-diamond-therapeutics, silevertinib, egfr-ncm-nsclc, fda-end-of-phase-2, bdtx-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/black-diamond-silevertinib-86-cns-orr-fda-pivotal-egfr-ncm</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:48:05.668Z</news:publication_date>
      <news:title>Black Diamond Hits 86% CNS-ORR, FDA Backs Pivotal Path</news:title>
      <news:keywords>black-diamond-therapeutics, silevertinib, egfr-ncm-nsclc, fda-end-of-phase-2, bdtx-stock</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/keenova-q3-2026-xiaflex-82-guidance-alzata</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:47:08.939Z</news:publication_date>
      <news:title>Keenova Q3 2026: XIAFLEX +82%, guidance alzata</news:title>
      <news:keywords>keenova-therapeutics, xiaflex, acthar-gel, pharma-earnings, merger-synergies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/keenova-xiaflex-上调指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:47:08.939Z</news:publication_date>
      <news:title>Keenova 2026年第三季度：XIAFLEX 大涨82%，上调业绩指引</news:title>
      <news:keywords>keenova-therapeutics, xiaflex, acthar-gel, pharma-earnings, merger-synergies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/keenova-q3-2026-xiaflex-sube-82-guidance-elevada</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:47:08.939Z</news:publication_date>
      <news:title>Keenova Q3 2026: XIAFLEX sube 82%, guidance elevada</news:title>
      <news:keywords>keenova-therapeutics, xiaflex, acthar-gel, pharma-earnings, merger-synergies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/keenova-t3-2026-xiaflex-bondit-82-previsions-relevees</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:47:08.939Z</news:publication_date>
      <news:title>Keenova T3 2026 : XIAFLEX bondit de 82 %, prévisions relevées</news:title>
      <news:keywords>keenova-therapeutics, xiaflex, acthar-gel, pharma-earnings, merger-synergies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/keenova-q3-2026-xiaflex-jumps-82-percent-guidance-raised</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:47:08.939Z</news:publication_date>
      <news:title>Keenova Q3 2026: XIAFLEX Jumps 82%, Guidance Raised</news:title>
      <news:keywords>keenova-therapeutics, xiaflex, acthar-gel, pharma-earnings, merger-synergies</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/sono比特币财库q3扭亏</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:35:51.755Z</news:publication_date>
      <news:title>Sono Group比特币财库策略推动Q3扭亏为盈60万美元</news:title>
      <news:keywords>sono-group, bitcoin-treasury, ssm-stock, covered-call-strategy, delaware-redomiciliation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/sono-group-beneficio-bitcoin-tesoreria-aviso-continuidad-vencimientos</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:35:51.755Z</news:publication_date>
      <news:title>Sono Group logra 0,6 M$ de beneficio en el T3 por su tesorería de Bitcoin</news:title>
      <news:keywords>sono-group, bitcoin-treasury, ssm-stock, covered-call-strategy, delaware-redomiciliation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/sono-group-benefice-t3-2026-tresorerie-bitcoin</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:35:51.755Z</news:publication_date>
      <news:title>Sono Group renoue avec un bénéfice de 0,6 M$ au T3 grâce au Bitcoin</news:title>
      <news:keywords>sono-group, bitcoin-treasury, ssm-stock, covered-call-strategy, delaware-redomiciliation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/sono-group-utile-q3-2026-tesorerie-bitcoin</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:35:51.754Z</news:publication_date>
      <news:title>Sono Group chiude il Q3 con 0,6 mln $ di utile grazie al Bitcoin</news:title>
      <news:keywords>sono-group, bitcoin-treasury, ssm-stock, covered-call-strategy, delaware-redomiciliation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/sono-group-q3-2026-bitcoin-treasury-net-income-ssm</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:35:51.754Z</news:publication_date>
      <news:title>Sono Group Swings to $0.6M Q3 Profit on Bitcoin Treasury</news:title>
      <news:keywords>sono-group, bitcoin-treasury, ssm-stock, covered-call-strategy, delaware-redomiciliation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/transdigm四季度eps增33</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:34:52.245Z</news:publication_date>
      <news:title>TransDigm第四季度每股收益跃升33%，销售额达29.9亿美元，上调2027财年指引</news:title>
      <news:keywords>transdigm, tdg, aerospace-equities, earnings, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/transdigm-q4-bpa-sube-33-ventas-2990-m-guia-fy27-al-alza</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:34:52.244Z</news:publication_date>
      <news:title>TransDigm Q4 BPA sube 33% con ventas de 2.990 M$, guía FY27 al alza</news:title>
      <news:keywords>transdigm, tdg, aerospace-equities, earnings, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/transdigm-t4-bpa-bondit-33-pourcent-ventes-2-99-md-previsions-fy27-relevees</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:34:52.244Z</news:publication_date>
      <news:title>TransDigm T4 BPA bondit de 33%, ventes à 2,99 Md$, prévisions FY27 relevées</news:title>
      <news:keywords>transdigm, tdg, aerospace-equities, earnings, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/transdigm-eps-q4-crescita-33percento-guidance-fy27-rialzo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:34:52.244Z</news:publication_date>
      <news:title>TransDigm Q4: EPS +33%, vendite a 2,99 mld $, guidance FY27 in rialzo</news:title>
      <news:keywords>transdigm, tdg, aerospace-equities, earnings, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/transdigm-tdg-fiscal-2026-q4-results-eps-sales-fy27-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:34:52.244Z</news:publication_date>
      <news:title>TransDigm Q4 EPS Jumps 33% as Sales Hit $2.99B, Guides FY27 Higher</news:title>
      <news:keywords>transdigm, tdg, aerospace-equities, earnings, fy27-guidance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/chs-12-4亿美元票据置换</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:28:45.143Z</news:publication_date>
      <news:title>CHS以10.250%新票据置换6.875%旧票据，完成12.4亿美元再融资</news:title>
      <news:keywords>community-health-systems, cyh, exchange-offer, senior-secured-notes, high-yield-debt, consent-solicitation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/chs-canjea-notas-6-875-por-10-250-refinanciacion-1240-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:28:45.143Z</news:publication_date>
      <news:title>CHS canjea notas del 6,875% por el 10,250% en refi de $1.240M</news:title>
      <news:keywords>community-health-systems, cyh, exchange-offer, senior-secured-notes, high-yield-debt, consent-solicitation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/chs-scambia-note-6-875-con-10-250-rifinanziamento-1-24-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:28:45.142Z</news:publication_date>
      <news:title>CHS scambia note al 6,875% con il 10,250% in rifinanziamento da 1,24 mld</news:title>
      <news:keywords>community-health-systems, cyh, exchange-offer, senior-secured-notes, high-yield-debt, consent-solicitation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/chs-echange-obligations-6875-contre-10250-refinancement-124-md</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:28:45.142Z</news:publication_date>
      <news:title>CHS échange des obligations 6,875 % contre 10,250 % dans un refinancement de 1,24 Md$</news:title>
      <news:keywords>community-health-systems, cyh, exchange-offer, senior-secured-notes, high-yield-debt, consent-solicitation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/community-health-systems-exchange-offer-6-875-notes-10-250-2035</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:28:45.142Z</news:publication_date>
      <news:title>CHS Swaps 6.875% Notes for 10.250% in $1.24B Refi</news:title>
      <news:keywords>community-health-systems, cyh, exchange-offer, senior-secured-notes, high-yield-debt, consent-solicitation</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ampco-pittsburgh-beneficio-neto-tercer-trimestre-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:22:35.019Z</news:publication_date>
      <news:title>Ampco-Pittsburgh logra beneficio neto de 0,5 M$ en el tercer trimestre</news:title>
      <news:keywords>ampco-pittsburgh, ap-stock, q3-2026-earnings, forged-cast-engineered-products, air-liquid-processing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/安普科三季度扭亏为盈</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:22:35.019Z</news:publication_date>
      <news:title>Ampco-Pittsburgh第三季度净利润转正达50万美元</news:title>
      <news:keywords>ampco-pittsburgh, ap-stock, q3-2026-earnings, forged-cast-engineered-products, air-liquid-processing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ampco-pittsburgh-resultat-net-positif-t3-2026-reduction-dette</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:22:35.018Z</news:publication_date>
      <news:title>Ampco-Pittsburgh : résultat net positif de 0,5 M$ au T3</news:title>
      <news:keywords>ampco-pittsburgh, ap-stock, q3-2026-earnings, forged-cast-engineered-products, air-liquid-processing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ampco-pittsburgh-utile-netto-q3-2026-positivo-debito-ridotto</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:22:35.018Z</news:publication_date>
      <news:title>Ampco-Pittsburgh: utile netto Q3 positivo a 0,5 mln $</news:title>
      <news:keywords>ampco-pittsburgh, ap-stock, q3-2026-earnings, forged-cast-engineered-products, air-liquid-processing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ampco-pittsburgh-q3-2026-net-income-positive-debt-reduction</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:22:35.018Z</news:publication_date>
      <news:title>Ampco-Pittsburgh Q3 Net Income Turns Positive at $0.5M</news:title>
      <news:keywords>ampco-pittsburgh, ap-stock, q3-2026-earnings, forged-cast-engineered-products, air-liquid-processing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ten-holdings-cierra-oferta-2-millones-059-por-accion</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:16:27.602Z</news:publication_date>
      <news:title>TEN Holdings cierra oferta de 2,0 M$ a 0,59 $ por acción</news:title>
      <news:keywords>ten-holdings, xhld, nasdaq-offering, equity-dilution, microcap-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ten控股200万美元发行</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:16:27.602Z</news:publication_date>
      <news:title>TEN Holdings以每股$0.59完成200万美元发行</news:title>
      <news:keywords>ten-holdings, xhld, nasdaq-offering, equity-dilution, microcap-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ten-holdings-chiude-offerta-2-milioni-059-dollari-azione</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:16:27.601Z</news:publication_date>
      <news:title>TEN Holdings chiude offerta da 2,0 mln a 0,59 dollari per azione</news:title>
      <news:keywords>ten-holdings, xhld, nasdaq-offering, equity-dilution, microcap-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ten-holdings-cloture-offre-2-millions-059-dollar-action</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:16:27.601Z</news:publication_date>
      <news:title>TEN Holdings clôt une offre de 2,0 M$ à 0,59 $ par action</news:title>
      <news:keywords>ten-holdings, xhld, nasdaq-offering, equity-dilution, microcap-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ten-holdings-xhld-closes-2-million-offering-0-59-per-share</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:16:27.601Z</news:publication_date>
      <news:title>TEN Holdings Closes $2.0M Offering at $0.59 Per Share</news:title>
      <news:keywords>ten-holdings, xhld, nasdaq-offering, equity-dilution, microcap-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/原油跌破87美伊协议</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:15:28.219Z</news:publication_date>
      <news:title>美伊协议希望升温，原油跌破87.00关口</news:title>
      <news:keywords>crude-oil, us-iran-talks, oil-technical-analysis, uranium-enrichment, opec-risk-premium</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/crudo-rompe-bajo-87-esperanzas-acuerdo-eeuu-iran</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:15:28.218Z</news:publication_date>
      <news:title>El crudo rompe por debajo de 87,00 ante las esperanzas de acuerdo EEUU-Irán</news:title>
      <news:keywords>crude-oil, us-iran-talks, oil-technical-analysis, uranium-enrichment, opec-risk-premium</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/crude-oil-breaks-below-87-us-iran-deal-hopes-build</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:15:28.217Z</news:publication_date>
      <news:title>Crude Oil Breaks Below 87.00 as US-Iran Deal Hopes Build</news:title>
      <news:keywords>crude-oil, us-iran-talks, oil-technical-analysis, uranium-enrichment, opec-risk-premium</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/brut-casse-sous-87-espoirs-accord-us-iran-enrichissement-uranium</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:15:28.217Z</news:publication_date>
      <news:title>Le brut casse sous 87,00 sur les espoirs d&apos;accord US-Iran</news:title>
      <news:keywords>crude-oil, us-iran-talks, oil-technical-analysis, uranium-enrichment, opec-risk-premium</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/petrolio-rompe-sotto-87-speranze-accordo-usa-iran</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T11:15:28.217Z</news:publication_date>
      <news:title>Il petrolio rompe sotto 87,00 sulle speranze di accordo USA-Iran</news:title>
      <news:keywords>crude-oil, us-iran-talks, oil-technical-analysis, uranium-enrichment, opec-risk-premium</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/贝莱德警示2027ai支出放缓</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:13:07.135Z</news:publication_date>
      <news:title>贝莱德警示2027年AI支出放缓 美债可作对冲</news:title>
      <news:keywords>blackrock, ai-spending, treasury-yields, us-equities, capital-competition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/blackrock-desaceleracion-gasto-ia-2027-cobertura-tesoro</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:13:07.135Z</news:publication_date>
      <news:title>BlackRock señala una desaceleración del gasto en IA en 2027 como cobertura del Tesoro</news:title>
      <news:keywords>blackrock, ai-spending, treasury-yields, us-equities, capital-competition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/blackrock-ralentissement-depenses-ia-2027-couverture-treasury</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:13:07.134Z</news:publication_date>
      <news:title>BlackRock signale un ralentissement des dépenses IA en 2027 comme couverture Treasury</news:title>
      <news:keywords>blackrock, ai-spending, treasury-yields, us-equities, capital-competition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/blackrock-rallentamento-spesa-ai-2027-hedge-treasury</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:13:07.133Z</news:publication_date>
      <news:title>BlackRock segnala rallentamento spesa AI nel 2027 come hedge Treasury</news:title>
      <news:keywords>blackrock, ai-spending, treasury-yields, us-equities, capital-competition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/blackrock-2027-ai-spending-slowdown-treasury-hedge-neutral-equities</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:13:07.133Z</news:publication_date>
      <news:title>BlackRock Flags 2027 AI Spending Slowdown as Treasury Hedge</news:title>
      <news:keywords>blackrock, ai-spending, treasury-yields, us-equities, capital-competition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ipc-ee-uu-cierre-sin-tasa-anual-subyacente-decide-diciembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:12:07.683Z</news:publication_date>
      <news:title>IPC de EE. UU.: el cierre deja sin tasa anual y el dato subyacente decide diciembre</news:title>
      <news:keywords>us-cpi, core-inflation, federal-reserve, treasury-yields, bls-shutdown-data-gap</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/美国cpi停摆核心数据</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:12:07.683Z</news:publication_date>
      <news:title>美国CPI前瞻：政府停摆致无年度通胀率，核心数据决定12月政策</news:title>
      <news:keywords>us-cpi, core-inflation, federal-reserve, treasury-yields, bls-shutdown-data-gap</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/apercu-ipc-americain-shutdown-pas-de-taux-annuel-core-decembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:12:07.683Z</news:publication_date>
      <news:title>Aperçu de l&apos;IPC américain : pas de taux annuel, le core décide décembre</news:title>
      <news:keywords>us-cpi, core-inflation, federal-reserve, treasury-yields, bls-shutdown-data-gap</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/anteprima-cpi-usa-shutdown-tasso-annuo-core-decide-dicembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:12:07.683Z</news:publication_date>
      <news:title>Anteprima CPI USA: shutdown cancella il tasso annuo, il core decide dicembre</news:title>
      <news:keywords>us-cpi, core-inflation, federal-reserve, treasury-yields, bls-shutdown-data-gap</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/us-cpi-preview-october-shutdown-no-annual-rate-core-print-december-fed</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:12:07.682Z</news:publication_date>
      <news:title>US CPI Preview: Shutdown Leaves No Annual Rate, Core Print Decides December</news:title>
      <news:keywords>us-cpi, core-inflation, federal-reserve, treasury-yields, bls-shutdown-data-gap</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/日本家庭支出暴跌6-8</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:06:04.964Z</news:publication_date>
      <news:title>日本家庭支出暴跌6.8%，连续第十次下滑</news:title>
      <news:keywords>japan-household-spending, bank-of-japan, boj-december-hike, jpy, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/gasto-hogares-japon-cae-68-decima-bajada-consecutiva-boj</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:06:04.964Z</news:publication_date>
      <news:title>El gasto de los hogares japoneses cae un 6,8%, décima bajada consecutiva</news:title>
      <news:keywords>japan-household-spending, bank-of-japan, boj-december-hike, jpy, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/depenses-menages-japon-plongeon-6-8-pourcent-dixieme-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:06:04.964Z</news:publication_date>
      <news:title>Dépenses des ménages japonais : -6,8 %, 10e baisse d&apos;affilée</news:title>
      <news:keywords>japan-household-spending, bank-of-japan, boj-december-hike, jpy, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/spesa-famiglie-giappone-crolla-68-decimo-calo-consecutivo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:06:04.964Z</news:publication_date>
      <news:title>Spesa famiglie Giappone crolla 6,8%, decimo calo</news:title>
      <news:keywords>japan-household-spending, bank-of-japan, boj-december-hike, jpy, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/japan-household-spending-plunges-6-8-tenth-straight-drop-boj-december-hike</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:06:04.963Z</news:publication_date>
      <news:title>Japan Household Spending Plunges 6.8%, 10th Straight Drop</news:title>
      <news:keywords>japan-household-spending, bank-of-japan, boj-december-hike, jpy, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/actas-boj-subidas-mas-rapidas-yen-apuesta-15-diciembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:05:08.930Z</news:publication_date>
      <news:title>Las actas del BoJ respaldan subidas más rápidas, el yen se fortalece por la apuesta de 1,5% en diciembre</news:title>
      <news:keywords>boj, bank-of-japan, jpy, usd-jpy, jgb-yields, monetary-policy, neutral-rate, yen</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/日本央行纪要加息日元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:05:08.930Z</news:publication_date>
      <news:title>日本央行会议纪要支持加快加息，日元因12月加息至1.5%的押注走强</news:title>
      <news:keywords>boj, bank-of-japan, jpy, usd-jpy, jgb-yields, monetary-policy, neutral-rate, yen</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/boj-compte-rendu-hausses-plus-rapides-yen-decembre-1-5</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:05:08.929Z</news:publication_date>
      <news:title>Le compte rendu de la BoJ soutient des hausses plus rapides, le yen se raffermit sur une hausse de 1,5 % en décembre</news:title>
      <news:keywords>boj, bank-of-japan, jpy, usd-jpy, jgb-yields, monetary-policy, neutral-rate, yen</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/verbali-boj-sostengono-rialzi-rapidi-yen-forte-scommessa-dicembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:05:08.928Z</news:publication_date>
      <news:title>Verbali BoJ sostengono rialzi rapidi, yen forte su scommessa dicembre 1,5%</news:title>
      <news:keywords>boj, bank-of-japan, jpy, usd-jpy, jgb-yields, monetary-policy, neutral-rate, yen</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/boj-opinions-faster-hikes-neutral-rate-above-1-percent-yen</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T00:05:08.928Z</news:publication_date>
      <news:title>BoJ Minutes Back Faster Hikes, Yen Firms on 1.5% December Bet</news:title>
      <news:keywords>boj, bank-of-japan, jpy, usd-jpy, jgb-yields, monetary-policy, neutral-rate, yen</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/bitcoin-correzione-abc-testa-media-200-giorni-75106</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:18:22.025Z</news:publication_date>
      <news:title>Bitcoin scivola a 75.106 $ mentre la correzione ABC testa la media a 200 giorni</news:title>
      <news:keywords>bitcoin, btc-price-analysis, 200-day-moving-average, abc-correction, crypto-support-resistance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/比特币abc调整测试200日均线</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:18:22.025Z</news:publication_date>
      <news:title>比特币跌至75,106美元，ABC调整测试200日均线</news:title>
      <news:keywords>bitcoin, btc-price-analysis, 200-day-moving-average, abc-correction, crypto-support-resistance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/bitcoin-correccion-abc-prueba-media-movil-200-dias</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:18:22.025Z</news:publication_date>
      <news:title>Bitcoin cae a 75.106 $ mientras la corrección ABC pone a prueba la MM de 200 días</news:title>
      <news:keywords>bitcoin, btc-price-analysis, 200-day-moving-average, abc-correction, crypto-support-resistance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/bitcoin-glisse-75-106-correction-abc-teste-moyenne-200-jours</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:18:22.025Z</news:publication_date>
      <news:title>Bitcoin glisse à 75 106 $, la correction ABC teste la MM 200 jours</news:title>
      <news:keywords>bitcoin, btc-price-analysis, 200-day-moving-average, abc-correction, crypto-support-resistance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/bitcoin-abc-correction-tests-200-day-moving-average-support</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:18:22.024Z</news:publication_date>
      <news:title>Bitcoin Slips to $75,106 as ABC Correction Tests 200-Day MA</news:title>
      <news:keywords>bitcoin, btc-price-analysis, 200-day-moving-average, abc-correction, crypto-support-resistance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/petrolio-sotto-medie-100-200-giorni-e-ritracciamento-50</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:17:32.403Z</news:publication_date>
      <news:title>Il petrolio scende sotto le medie a 100 e 200 giorni a 87$</news:title>
      <news:keywords>crude-oil, technical-analysis, moving-average, iran-war-premium, strait-of-hormuz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/原油跌破100日200日均线</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:17:32.403Z</news:publication_date>
      <news:title>原油跌破100日、200日均线，报87美元</news:title>
      <news:keywords>crude-oil, technical-analysis, moving-average, iran-war-premium, strait-of-hormuz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/crudo-cae-bajo-medias-100-200-sesiones-niveles-8693-8717</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:17:32.403Z</news:publication_date>
      <news:title>El crudo cae bajo sus medias de 100 y 200 sesiones en 87 dólares</news:title>
      <news:keywords>crude-oil, technical-analysis, moving-average, iran-war-premium, strait-of-hormuz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/petrole-brut-sous-moyennes-100-200-jours-confluence-87</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:17:32.403Z</news:publication_date>
      <news:title>Le brut sous ses moyennes 100 et 200 jours à 87 $</news:title>
      <news:keywords>crude-oil, technical-analysis, moving-average, iran-war-premium, strait-of-hormuz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/crude-oil-slips-below-100-day-200-day-moving-averages-87</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:17:32.403Z</news:publication_date>
      <news:title>Crude Oil Slips Below 100-Day, 200-Day Averages at $87</news:title>
      <news:keywords>crude-oil, technical-analysis, moving-average, iran-war-premium, strait-of-hormuz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/gestores-patrimonios-alcistas-tras-caida-nasdaq-piden-diversificar</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:16:38.945Z</news:publication_date>
      <news:title>Los gestores de patrimonios siguen alcistas tras una caída del 5,5% en el Nasdaq y piden diversificar</news:title>
      <news:keywords>ai-rout, wealth-managers, nasdaq-selloff, diversification, data-centre-policy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/纳斯达克暴跌5-5-财富管理机构看多</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:16:38.945Z</news:publication_date>
      <news:title>财富管理机构在纳斯达克暴跌5.5%后仍看多，呼吁分散配置</news:title>
      <news:keywords>ai-rout, wealth-managers, nasdaq-selloff, diversification, data-centre-policy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/gestionnaires-optimistes-apres-chute-nasdaq-diversification</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:16:38.945Z</news:publication_date>
      <news:title>Gérants optimistes après une chute de 5,5 % du Nasdaq</news:title>
      <news:keywords>ai-rout, wealth-managers, nasdaq-selloff, diversification, data-centre-policy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/gestori-rialzisti-dopo-crollo-nasdaq-5-5-diversificazione</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:16:38.944Z</news:publication_date>
      <news:title>Gestori restano rialzisti dopo il -5,5% del Nasdaq, spingono la diversificazione</news:title>
      <news:keywords>ai-rout, wealth-managers, nasdaq-selloff, diversification, data-centre-policy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/wealth-managers-constructive-equities-after-ai-rout-diversification</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:16:38.944Z</news:publication_date>
      <news:title>Wealth Managers Stay Bullish After 5.5% Nasdaq Rout, Urge Diversification</news:title>
      <news:keywords>ai-rout, wealth-managers, nasdaq-selloff, diversification, data-centre-policy</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/伊朗七条件霍尔木兹封锁</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:15:43.899Z</news:publication_date>
      <news:title>伊朗要求美国接受七项条件 霍尔木兹封锁持续</news:title>
      <news:keywords>iran-us-talks, strait-of-hormuz, oil-risk-premium, naval-blockade, geopolitics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/iran-exige-eeuu-siete-condiciones-bloqueo-ormuz-petroleo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:15:43.899Z</news:publication_date>
      <news:title>Irán exige a EE.UU. aceptar siete condiciones mientras mantiene el bloqueo de Ormuz</news:title>
      <news:keywords>iran-us-talks, strait-of-hormuz, oil-risk-premium, naval-blockade, geopolitics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/iran-exige-sept-conditions-blocage-ormuz-tient</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:15:43.898Z</news:publication_date>
      <news:title>L&apos;Iran exige des États-Unis sept conditions, le blocus d&apos;Ormuz tient</news:title>
      <news:keywords>iran-us-talks, strait-of-hormuz, oil-risk-premium, naval-blockade, geopolitics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/iran-sette-condizioni-blocco-hormuz-petrolio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:15:43.898Z</news:publication_date>
      <news:title>Iran chiede agli USA di accettare sette condizioni con il blocco di Hormuz</news:title>
      <news:keywords>iran-us-talks, strait-of-hormuz, oil-risk-premium, naval-blockade, geopolitics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/iran-seven-conditions-hormuz-blockade-oil-risk-premium</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:15:43.898Z</news:publication_date>
      <news:title>Iran Demands US Accept Seven Conditions as Hormuz Blockade Holds</news:title>
      <news:keywords>iran-us-talks, strait-of-hormuz, oil-risk-premium, naval-blockade, geopolitics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/goldman-1500-milliards-dette-ia-pesent-sur-le-credit</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:14:49.413Z</news:publication_date>
      <news:title>Goldman : 1 500 Md$ de dette IA pèsent sur le crédit</news:title>
      <news:keywords>goldman-sachs, ai-debt, investment-grade-credit, hyperscaler-bonds, ai-capex</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/高盛警告1-5万亿ai债务</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:14:49.413Z</news:publication_date>
      <news:title>高盛警告1.5万亿美元AI债务供应拖累信贷</news:title>
      <news:keywords>goldman-sachs, ai-debt, investment-grade-credit, hyperscaler-bonds, ai-capex</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/goldman-avisa-deuda-ia-1-5-billones-presiona-credito</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:14:49.413Z</news:publication_date>
      <news:title>Goldman avisa: la oferta de deuda de IA de 1,5 billones presiona el crédito</news:title>
      <news:keywords>goldman-sachs, ai-debt, investment-grade-credit, hyperscaler-bonds, ai-capex</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/goldman-offerta-debito-ai-15-trilioni-pesa-credito</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:14:49.412Z</news:publication_date>
      <news:title>Goldman avverte: l&apos;offerta di debito AI da 1,5 trilioni pesa sul credito</news:title>
      <news:keywords>goldman-sachs, ai-debt, investment-grade-credit, hyperscaler-bonds, ai-capex</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/goldman-1-5-trillion-ai-debt-supply-weighs-on-credit-spreads</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:14:49.411Z</news:publication_date>
      <news:title>Goldman Warns $1.5T AI Debt Supply Weighs on Credit</news:title>
      <news:keywords>goldman-sachs, ai-debt, investment-grade-credit, hyperscaler-bonds, ai-capex</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/摩根士丹利澳元ai情绪交易</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:08:46.797Z</news:publication_date>
      <news:title>摩根士丹利：民主党大胜后澳元成AI情绪风向标</news:title>
      <news:keywords>australian-dollar, morgan-stanley, ai-trade, fx-strategy, data-centres</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/morgan-stanley-aud-sentimiento-ia-barrida-democrata</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:08:46.796Z</news:publication_date>
      <news:title>Morgan Stanley señala al AUD como operación de sentimiento IA tras la barrida</news:title>
      <news:keywords>australian-dollar, morgan-stanley, ai-trade, fx-strategy, data-centres</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/morgan-stanley-aud-trade-sentiment-ai-sweep-democratica</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:08:46.787Z</news:publication_date>
      <news:title>Morgan Stanley: l&apos;AUD è un trade sul sentiment AI dopo la sweep</news:title>
      <news:keywords>australian-dollar, morgan-stanley, ai-trade, fx-strategy, data-centres</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/morgan-stanley-aud-trade-sentiment-ia-balayage-democrate</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:08:46.787Z</news:publication_date>
      <news:title>Morgan Stanley voit dans l&apos;AUD un trade sur le sentiment IA</news:title>
      <news:keywords>australian-dollar, morgan-stanley, ai-trade, fx-strategy, data-centres</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/morgan-stanley-flags-aud-ai-sentiment-trade-after-democratic-sweep</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:08:46.787Z</news:publication_date>
      <news:title>Morgan Stanley Flags AUD as AI Sentiment Trade After Sweep</news:title>
      <news:keywords>australian-dollar, morgan-stanley, ai-trade, fx-strategy, data-centres</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/morgan-stanley-comprar-caida-ia-capex-hiperscaler-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:16:53.125Z</news:publication_date>
      <news:title>Morgan Stanley: comprar la caída de la IA, capex hiperscaler de 3,4 billones hasta 2028</news:title>
      <news:keywords>morgan-stanley, ai-capex, hyperscaler, data-center, nvidia</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/摩根士丹利看多ai超大规模资本支出</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:16:53.125Z</news:publication_date>
      <news:title>摩根士丹利：逢低买入AI，2028年超大规模资本支出达3.4万亿美元</news:title>
      <news:keywords>morgan-stanley, ai-capex, hyperscaler, data-center, nvidia</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/morgan-stanley-acheter-baisse-ia-capex-hyperscaler-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:16:53.125Z</news:publication_date>
      <news:title>Morgan Stanley : acheter la baisse de l&apos;IA, 3,4 T$ de capex hyperscaler d&apos;ici 2028</news:title>
      <news:keywords>morgan-stanley, ai-capex, hyperscaler, data-center, nvidia</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/morgan-stanley-buy-ai-dip-hyperscaler-capex-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:16:53.124Z</news:publication_date>
      <news:title>Morgan Stanley: Buy AI Dip, $3.4T Hyperscaler Capex to 2028</news:title>
      <news:keywords>morgan-stanley, ai-capex, hyperscaler, data-center, nvidia</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/morgan-stanley-comprare-calo-ai-capex-hyperscaler-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:16:53.124Z</news:publication_date>
      <news:title>Morgan Stanley: comprare il calo AI, capex hyperscaler 3,4T$ al 2028</news:title>
      <news:keywords>morgan-stanley, ai-capex, hyperscaler, data-center, nvidia</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/日本央行意见摘要中国10月贸易数据</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:15:49.027Z</news:publication_date>
      <news:title>日本央行意见摘要与中国10月贸易数据：亚洲周二</news:title>
      <news:keywords>boj, bank-of-japan, china-trade-data, jpy, csi-300</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/sintesi-opinioni-boj-dati-commercio-cina-ottobre-asia-martedi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:15:49.026Z</news:publication_date>
      <news:title>Sintesi opinioni BoJ, dati commercio Cina ottobre: Asia martedì</news:title>
      <news:keywords>boj, bank-of-japan, china-trade-data, jpy, csi-300</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/resumen-opiniones-boj-comercio-china-octubre-asia-martes</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:15:49.026Z</news:publication_date>
      <news:title>Resumen de opiniones del BoJ y comercio de China en octubre: Asia martes</news:title>
      <news:keywords>boj, bank-of-japan, china-trade-data, jpy, csi-300</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/resume-opinions-boj-commerce-chine-octobre-asie-mardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:15:49.026Z</news:publication_date>
      <news:title>Résumé des opinions de la BoJ, commerce chinois d&apos;octobre : Asie mardi</news:title>
      <news:keywords>boj, bank-of-japan, china-trade-data, jpy, csi-300</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/boj-summary-opinions-china-october-trade-data-asia-tuesday</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:15:49.025Z</news:publication_date>
      <news:title>BoJ Summary of Opinions, China October Trade Data: Asia Tuesday</news:title>
      <news:keywords>boj, bank-of-japan, china-trade-data, jpy, csi-300</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/anthropic-ipo-nasdaq-ticker-ant-objetivo-15-billones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:09:39.393Z</news:publication_date>
      <news:title>Anthropic solicita salir a bolsa en el Nasdaq con el ticker ANT y objetivo de 1,5 billones</news:title>
      <news:keywords>anthropic-ipo, nasdaq-ant, ai-stocks, claude-ai, tech-ipo-2026</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/anthropic申请纳斯达克ipo代码ant</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:09:39.393Z</news:publication_date>
      <news:title>Anthropic申请纳斯达克IPO，代码ANT，目标估值1.5万亿美元</news:title>
      <news:keywords>anthropic-ipo, nasdaq-ant, ai-stocks, claude-ai, tech-ipo-2026</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/anthropic-ipo-nasdaq-ticker-ant-valuation-1500-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:09:39.392Z</news:publication_date>
      <news:title>Anthropic dépose son IPO au Nasdaq sous le ticker ANT pour 1,5 T$</news:title>
      <news:keywords>anthropic-ipo, nasdaq-ant, ai-stocks, claude-ai, tech-ipo-2026</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/anthropic-ipo-nasdaq-ticker-ant-valutazione-1500-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:09:39.391Z</news:publication_date>
      <news:title>Anthropic deposita domanda IPO al Nasdaq con ticker ANT a 1,5 trilioni</news:title>
      <news:keywords>anthropic-ipo, nasdaq-ant, ai-stocks, claude-ai, tech-ipo-2026</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/anthropic-nasdaq-ipo-ticker-ant-1-5-trillion-valuation-target</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:09:39.391Z</news:publication_date>
      <news:title>Anthropic Files for Nasdaq IPO Under Ticker ANT at $1.5T Target</news:title>
      <news:keywords>anthropic-ipo, nasdaq-ant, ai-stocks, claude-ai, tech-ipo-2026</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/特朗普伊朗封锁布伦特98</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:08:36.149Z</news:publication_date>
      <news:title>特朗普称重启对伊打击&quot;相当不可能&quot;，布伦特原油持稳于98美元附近</news:title>
      <news:keywords>iran-oil, brent-crude, strait-of-hormuz, us-naval-blockade, iron-gate-task-force</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/trump-iran-ataques-poco-probables-brent-98-bloqueo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:08:36.149Z</news:publication_date>
      <news:title>Trump ve &quot;poco probable&quot; nuevos ataques a Irán mientras el Brent ronda los 98 $</news:title>
      <news:keywords>iran-oil, brent-crude, strait-of-hormuz, us-naval-blockade, iron-gate-task-force</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/trump-frappes-iran-peu-probables-brent-blocage-golfe</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:08:36.149Z</news:publication_date>
      <news:title>Trump juge peu probable une reprise des frappes en Iran, Brent près de 98 $</news:title>
      <news:keywords>iran-oil, brent-crude, strait-of-hormuz, us-naval-blockade, iron-gate-task-force</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/trump-iran-strikes-unlikely-brent-oil-blockade-hormuz</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:08:36.148Z</news:publication_date>
      <news:title>Trump Calls Renewed Iran Strikes &apos;Quite Unlikely&apos; as Brent Holds Near $98</news:title>
      <news:keywords>iran-oil, brent-crude, strait-of-hormuz, us-naval-blockade, iron-gate-task-force</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/trump-attacchi-iran-poco-probabili-brent-vicino-98-dollari</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:08:36.148Z</news:publication_date>
      <news:title>Trump: nuovi attacchi all&apos;Iran &apos;poco probabili&apos;, Brent vicino a $98</news:title>
      <news:keywords>iran-oil, brent-crude, strait-of-hormuz, us-naval-blockade, iron-gate-task-force</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/airi三季度扭亏为盈</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:26.161Z</news:publication_date>
      <news:title>Air Industries第三季度净利润转正，每股收益0.19美元</news:title>
      <news:keywords>air-industries-group, airi, aerospace-defense, q3-2026-earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/air-industries-q3-beneficio-neto-positivo-bpa-019</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:26.161Z</news:publication_date>
      <news:title>Air Industries Q3 beneficio neto positivo con BPA de $0.19</news:title>
      <news:keywords>air-industries-group, airi, aerospace-defense, q3-2026-earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/air-industries-benefice-net-t3-positif-bpa-019-dollar</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:26.159Z</news:publication_date>
      <news:title>Air Industries : bénéfice net positif au T3, BPA de 0,19 $</news:title>
      <news:keywords>air-industries-group, airi, aerospace-defense, q3-2026-earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/air-industries-utile-netto-q3-positivo-eps-0-19</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:26.159Z</news:publication_date>
      <news:title>Air Industries: utile netto Q3 positivo, EPS $0,19</news:title>
      <news:keywords>air-industries-group, airi, aerospace-defense, q3-2026-earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/air-industries-q3-2026-net-income-eps-adj</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:26.159Z</news:publication_date>
      <news:title>Air Industries Q3 Net Income Turns Positive at $0.19 EPS</news:title>
      <news:keywords>air-industries-group, airi, aerospace-defense, q3-2026-earnings, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/viridian-vrdn-008降低igg74</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:36:14.242Z</news:publication_date>
      <news:title>Viridian的VRDN-008降低IgG达74%，瞄准每8周给药</news:title>
      <news:keywords>viridian-therapeutics, vrdn-008, fcrn-inhibitor, myasthenia-gravis, autoimmune-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/viridian-vrdn-008-riduce-igg-74-dosaggio-ogni-8-settimane</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:36:14.241Z</news:publication_date>
      <news:title>VRDN-008 di Viridian riduce IgG del 74%, punta a dosaggio Q8W</news:title>
      <news:keywords>viridian-therapeutics, vrdn-008, fcrn-inhibitor, myasthenia-gravis, autoimmune-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/viridian-vrdn-008-reduce-igg-74-por-ciento-dosis-cada-8-semanas</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:36:14.241Z</news:publication_date>
      <news:title>VRDN-008 de Viridian reduce IgG un 74% y apunta a dosis cada 8 semanas</news:title>
      <news:keywords>viridian-therapeutics, vrdn-008, fcrn-inhibitor, myasthenia-gravis, autoimmune-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/viridian-vrdn-008-reduction-igg-74-pourcent-dosage-q8w</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:36:14.241Z</news:publication_date>
      <news:title>VRDN-008 de Viridian réduit les IgG de 74 %, vise Q8W</news:title>
      <news:keywords>viridian-therapeutics, vrdn-008, fcrn-inhibitor, myasthenia-gravis, autoimmune-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/viridian-vrdn-008-phase-1-igg-reduction-q8w-dosing-myasthenia-gravis</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:36:14.241Z</news:publication_date>
      <news:title>Viridian&apos;s VRDN-008 Cuts IgG 74%, Eyes Q8W Dosing</news:title>
      <news:keywords>viridian-therapeutics, vrdn-008, fcrn-inhibitor, myasthenia-gravis, autoimmune-biotech</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/hain-celestial-净销售额下降29-aurelius交易停滞</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:30:10.627Z</news:publication_date>
      <news:title>Hain Celestial第一财季净销售额下降29%至2.6亿美元</news:title>
      <news:keywords>hain-celestial, hain-earnings, international-sale, aurelius, consumer-staples</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/hain-celestial-ventas-t1-caen-29-260-millones-aurelius-apalancamiento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:30:10.626Z</news:publication_date>
      <news:title>Hain Celestial: ventas netas del T1 caen 29% a 260 millones $</news:title>
      <news:keywords>hain-celestial, hain-earnings, international-sale, aurelius, consumer-staples</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/hain-celestial-vendite-q1-calo-29percento-260-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:30:10.625Z</news:publication_date>
      <news:title>Hain Celestial: vendite nette Q1 -29% a 260 milioni $</news:title>
      <news:keywords>hain-celestial, hain-earnings, international-sale, aurelius, consumer-staples</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/hain-celestial-ventes-en-baisse-de-29-pourcent-aurelius</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:30:10.625Z</news:publication_date>
      <news:title>Hain Celestial : ventes nettes en baisse de 29% à 260 M$</news:title>
      <news:keywords>hain-celestial, hain-earnings, international-sale, aurelius, consumer-staples</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/hain-celestial-q1-fy27-net-sales-fall-29-percent-international-sale</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:30:10.625Z</news:publication_date>
      <news:title>Hain Celestial Q1 Net Sales Fall 29% to $260 Million</news:title>
      <news:keywords>hain-celestial, hain-earnings, international-sale, aurelius, consumer-staples</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ocular-therapeutix第三季度亏损axpaxli-nda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:29:07.290Z</news:publication_date>
      <news:title>Ocular Therapeutix第三季度亏损9480万美元，NDA按计划推进</news:title>
      <news:keywords>ocular-therapeutix, ocul-stock, axpaxli, wet-amd, biotech-nda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ocular-therapeutix-perdida-t3-nda-axpaxli-en-plazo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:29:07.290Z</news:publication_date>
      <news:title>Ocular Therapeutix pierde 94,8 M$ en el T3 y su NDA sigue en plazo</news:title>
      <news:keywords>ocular-therapeutix, ocul-stock, axpaxli, wet-amd, biotech-nda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ocular-therapeutix-q3-2026-net-loss-axpaxli-nda-505b2</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:29:07.289Z</news:publication_date>
      <news:title>Ocular Therapeutix Posts $94.8M Q3 Loss, NDA on Track</news:title>
      <news:keywords>ocular-therapeutix, ocul-stock, axpaxli, wet-amd, biotech-nda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ocular-therapeutix-perte-t3-nda-axpaxli-en-bonne-voie</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:29:07.289Z</news:publication_date>
      <news:title>Ocular Therapeutix : perte de 94,8 M$ au T3, NDA en bonne voie</news:title>
      <news:keywords>ocular-therapeutix, ocul-stock, axpaxli, wet-amd, biotech-nda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ocular-therapeutix-perdita-q3-nda-axpaxli-in-linea</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:29:07.289Z</news:publication_date>
      <news:title>Ocular Therapeutix: perdita di 94,8 mln nel Q3, NDA in linea</news:title>
      <news:keywords>ocular-therapeutix, ocul-stock, axpaxli, wet-amd, biotech-nda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/immunovant-acr20干燥综合征退出</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:28:06.971Z</news:publication_date>
      <news:title>Immunovant ACR20告捷难掩干燥综合征退出，现金7.22亿美元</news:title>
      <news:keywords>immunovant, imvt-1402, rheumatoid-arthritis, biotech-earnings, acr20</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/immunovant-vittoria-acr20-uscita-sjogren-cash-722-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:28:06.970Z</news:publication_date>
      <news:title>Immunovant: vittoria ACR20 maschera l&apos;uscita da Sjogren, cash $722M</news:title>
      <news:keywords>immunovant, imvt-1402, rheumatoid-arthritis, biotech-earnings, acr20</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/immunovant-acr20-600mg-abandona-sjogrens-722-millones-caja</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:28:06.970Z</news:publication_date>
      <news:title>Immunovant logra ACR20 pero abandona Sjogren&apos;s, $722M en caja</news:title>
      <news:keywords>immunovant, imvt-1402, rheumatoid-arthritis, biotech-earnings, acr20</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/immunovant-succes-acr20-abandon-sjogren-tresorerie-722-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:28:06.970Z</news:publication_date>
      <news:title>Immunovant : succès ACR20 masque l&apos;abandon de Sjogren, 722 M$ de trésorerie</news:title>
      <news:keywords>immunovant, imvt-1402, rheumatoid-arthritis, biotech-earnings, acr20</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/immunovant-imvt-1402-acr20-rheumatoid-arthritis-sjogren-exit</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:28:06.970Z</news:publication_date>
      <news:title>Immunovant ACR20 Win Masks Sjogren&apos;s Exit, $722M Cash</news:title>
      <news:keywords>immunovant, imvt-1402, rheumatoid-arthritis, biotech-earnings, acr20</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/akamai-convertible-senior-notes-2028-2031-offering-repay-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:27:06.777Z</news:publication_date>
      <news:title>Akamai Prices $2.2B Convertible Notes, 2027 Maturity Repay</news:title>
      <news:keywords>akamai-convertible-notes, akam-convertible-debt, cloud-infrastructure-capex, convertible-note-hedge, rule-144a-offering</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/akamai22亿可转债偿还2027债务</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:27:06.777Z</news:publication_date>
      <news:title>Akamai为22亿美元可转换票据定价，2027年到期债务偿还</news:title>
      <news:keywords>akamai-convertible-notes, akam-convertible-debt, cloud-infrastructure-capex, convertible-note-hedge, rule-144a-offering</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/akamai-convertibles-2200-millones-refinanciar-deuda-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:27:06.777Z</news:publication_date>
      <news:title>Akamai fija 2.200M$ en convertibles, vencimiento 2027 a refinanciar</news:title>
      <news:keywords>akamai-convertible-notes, akam-convertible-debt, cloud-infrastructure-capex, convertible-note-hedge, rule-144a-offering</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/akamai-obligations-convertibles-2-2-milliards-remboursement-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:27:06.777Z</news:publication_date>
      <news:title>Akamai fixe 2,2 Md$ d&apos;obligations convertibles, échéance 2027 remboursée</news:title>
      <news:keywords>akamai-convertible-notes, akam-convertible-debt, cloud-infrastructure-capex, convertible-note-hedge, rule-144a-offering</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/akamai-prezza-22-miliardi-convertibili-rimborso-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:27:06.777Z</news:publication_date>
      <news:title>Akamai prezza 2,2 mld di convertibili, rimborso 2027</news:title>
      <news:keywords>akamai-convertible-notes, akam-convertible-debt, cloud-infrastructure-capex, convertible-note-hedge, rule-144a-offering</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/superior集团q3净销售额增5</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:26:06.280Z</news:publication_date>
      <news:title>Superior Group第三季度净销售额增长5%至1.46亿美元，每股收益持平于0.17美元</news:title>
      <news:keywords>superior-group-of-companies, SGC-earnings, Q3-2026-results, branded-products-segment, contact-centers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/superior-group-ventas-t3-suben-5-bpa-plano-146-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:26:06.280Z</news:publication_date>
      <news:title>Superior Group: ventas netas del T3 suben 5% a 146 M$, BPA plano en 0,17 $</news:title>
      <news:keywords>superior-group-of-companies, SGC-earnings, Q3-2026-results, branded-products-segment, contact-centers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/superior-group-companies-q3-2026-net-sales-146-million-eps-flat</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:26:06.279Z</news:publication_date>
      <news:title>Superior Group Q3 Net Sales Rise 5% to $146M, EPS Flat at $0.17</news:title>
      <news:keywords>superior-group-of-companies, SGC-earnings, Q3-2026-results, branded-products-segment, contact-centers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/superior-group-t3-2026-ventes-bpa-ebitda-sante-apparel</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:26:06.279Z</news:publication_date>
      <news:title>Superior Group T3 : ventes nettes +5% à 146 M$, BPA stable à 0,17 $</news:title>
      <news:keywords>superior-group-of-companies, SGC-earnings, Q3-2026-results, branded-products-segment, contact-centers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/superior-group-vendite-q3-2026-crescita-eps-stabile-abbigliamento-sanitario</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:26:06.279Z</news:publication_date>
      <news:title>Superior Group: vendite Q3 +5% a 146 M$, EPS stabile a 0,17 $</news:title>
      <news:keywords>superior-group-of-companies, SGC-earnings, Q3-2026-results, branded-products-segment, contact-centers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/powerfleet-ricavi-record-q2-115-mln-conferma-guidance-fy2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:25:01.064Z</news:publication_date>
      <news:title>Powerfleet: ricavi Q2 record a 115,7 mln $, conferma FY2027</news:title>
      <news:keywords>powerfleet, aiot-saas, earnings, nasdaq-aiot, device-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/powerfleet二季度营收创纪录</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:25:01.064Z</news:publication_date>
      <news:title>Powerfleet第二季度营收创纪录达1.157亿美元，重申2027财年指引</news:title>
      <news:keywords>powerfleet, aiot-saas, earnings, nasdaq-aiot, device-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/powerfleet-ingresos-record-1157-millones-confirma-previsiones-ejercicio-202</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:25:01.064Z</news:publication_date>
      <news:title>Powerfleet logra ingresos récord de 115,7 M$ en el segundo trimestre y confirma el ejercicio 2027</news:title>
      <news:keywords>powerfleet, aiot-saas, earnings, nasdaq-aiot, device-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/powerfleet-revenu-record-q2-previsions-fy2027-confirmees</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:25:01.064Z</news:publication_date>
      <news:title>Powerfleet Q2 : revenu record de 115,7 M$, prévisions FY2027 confirmées</news:title>
      <news:keywords>powerfleet, aiot-saas, earnings, nasdaq-aiot, device-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/powerfleet-q2-fiscal-2027-record-revenue-115-7-million-affirms-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:25:01.063Z</news:publication_date>
      <news:title>Powerfleet Q2 Revenue Hits Record $115.7M, Affirms FY2027</news:title>
      <news:keywords>powerfleet, aiot-saas, earnings, nasdaq-aiot, device-financing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/roivant-lisraya-imvt-1402类风湿</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:23:56.531Z</news:publication_date>
      <news:title>Roivant公布LISRAYA上市收入3100万美元，IMVT-1402达到RA终点</news:title>
      <news:keywords>roivant-sciences, imvt-1402, brepocitinib, immunovant, lisraya-launch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/roivant-lisraya-31m-imvt-1402-endpoint-artritis-reumatoide</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:23:56.531Z</news:publication_date>
      <news:title>Roivant registra 31 M$ en lanzamiento de LISRAYA, IMVT-1402 cumple en AR</news:title>
      <news:keywords>roivant-sciences, imvt-1402, brepocitinib, immunovant, lisraya-launch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/roivant-lisraya-31-milioni-imvt-1402-endpoint-arthritis-reumatoide</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:23:56.530Z</news:publication_date>
      <news:title>Roivant: lancio LISRAYA da 31 mln, IMVT-1402 centra endpoint RA</news:title>
      <news:keywords>roivant-sciences, imvt-1402, brepocitinib, immunovant, lisraya-launch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/roivant-lisraya-31-millions-imvt-1402-critere-rac</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:23:56.530Z</news:publication_date>
      <news:title>Roivant : lancement LISRAYA à 31 M$, IMVT-1402 atteint le critère RA</news:title>
      <news:keywords>roivant-sciences, imvt-1402, brepocitinib, immunovant, lisraya-launch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/roivant-sciences-q2-fy2026-lisraya-31m-imvt-1402-rheumatoid-arthritis</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:23:56.529Z</news:publication_date>
      <news:title>Roivant Posts $31M LISRAYA Launch, IMVT-1402 Hits RA Endpoint</news:title>
      <news:keywords>roivant-sciences, imvt-1402, brepocitinib, immunovant, lisraya-launch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/tonix-tonmya现金消耗</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:22:48.479Z</news:publication_date>
      <news:title>Tonix TONMYA销售额达1500万美元，TNXP现金消耗翻三倍</news:title>
      <news:keywords>tonix-pharmaceuticals, tnxp, tonmya, fibromyalgia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/tonix-tonmya-ventas-15-millones-quema-caja-triplica-tnxp</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:22:48.479Z</news:publication_date>
      <news:title>Ventas de TONMYA de Tonix llegan a 15 M$ y quema de caja se triplica</news:title>
      <news:keywords>tonix-pharmaceuticals, tnxp, tonmya, fibromyalgia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/tonix-tonmya-vendite-15-milioni-cash-burn-triplica</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:22:48.478Z</news:publication_date>
      <news:title>Vendite TONMYA di Tonix a 15 milioni, il cash burn TNXP triplica</news:title>
      <news:keywords>tonix-pharmaceuticals, tnxp, tonmya, fibromyalgia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/tonix-tonmya-15-millions-tresorerie-brulee-triplee</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:22:48.478Z</news:publication_date>
      <news:title>Ventes TONMYA de Tonix à 15 M$ et trésorerie brûlée ×3</news:title>
      <news:keywords>tonix-pharmaceuticals, tnxp, tonmya, fibromyalgia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/tonix-tonmya-q3-2026-net-sales-cash-burn-tnxp</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:22:48.478Z</news:publication_date>
      <news:title>Tonix TONMYA Sales Hit $15M as TNXP Cash Burn Triples</news:title>
      <news:keywords>tonix-pharmaceuticals, tnxp, tonmya, fibromyalgia, biotech-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/via-ricavi-31-percento-perdite-quasi-pareggio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:16:42.173Z</news:publication_date>
      <news:title>Via: ricavi +31% a 144 mln, perdite quasi in pareggio</news:title>
      <news:keywords>via-transportation, via-q3-2026-earnings, transit-software, mobility-tech, adjusted-ebitda-breakeven</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/via营收31-逼近盈亏平衡</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:16:42.173Z</news:publication_date>
      <news:title>Via营收飙升31%至1.44亿美元，亏损逼近盈亏平衡点</news:title>
      <news:keywords>via-transportation, via-q3-2026-earnings, transit-software, mobility-tech, adjusted-ebitda-breakeven</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/via-ingresos-31-144-millones-perdidas-cerca-equilibrio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:16:42.173Z</news:publication_date>
      <news:title>Via dispara sus ingresos un 31% hasta 144 M$ y roza el equilibrio</news:title>
      <news:keywords>via-transportation, via-q3-2026-earnings, transit-software, mobility-tech, adjusted-ebitda-breakeven</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/via-chiffre-affaires-31-pourcent-144-millions-pertes-equilibre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:16:42.173Z</news:publication_date>
      <news:title>Via : le chiffre d&apos;affaires bondit de 31% à 144 M$, pertes proches de l&apos;équilibre</news:title>
      <news:keywords>via-transportation, via-q3-2026-earnings, transit-software, mobility-tech, adjusted-ebitda-breakeven</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/via-transportation-q3-2026-revenue-31-percent-adjusted-net-loss-breakeven</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:16:42.173Z</news:publication_date>
      <news:title>Via Revenue Jumps 31% to $144M as Losses Near Breakeven</news:title>
      <news:keywords>via-transportation, via-q3-2026-earnings, transit-software, mobility-tech, adjusted-ebitda-breakeven</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ionis-taglia-guidance-tryngolza-2026-ricavi-q3-crescita</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:15:27.954Z</news:publication_date>
      <news:title>Ionis taglia la guidance 2026 di Tryngolza a 50 mln, ricavi Q3 +55%</news:title>
      <news:keywords>ionis-pharmaceuticals, ions-stock, tryngolza, olezarsen, dawnzera, biotech-earnings, rna-therapeutics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ionis下调tryngolza指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:15:27.954Z</news:publication_date>
      <news:title>Ionis将Tryngolza 2026年销售指引下调至5000万美元，Q3营收增长55%</news:title>
      <news:keywords>ionis-pharmaceuticals, ions-stock, tryngolza, olezarsen, dawnzera, biotech-earnings, rna-therapeutics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ionis-recorta-guia-tryngolza-2026-ingresos-t3-suben-55</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:15:27.954Z</news:publication_date>
      <news:title>Ionis recorta guía de ventas de Tryngolza 2026 a 50 M$ y sus ingresos del T3 suben un 55%</news:title>
      <news:keywords>ionis-pharmaceuticals, ions-stock, tryngolza, olezarsen, dawnzera, biotech-earnings, rna-therapeutics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ionis-reduit-objectif-tryngolza-2026-chiffre-affaires-t3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:15:27.954Z</news:publication_date>
      <news:title>Ionis réduit l&apos;objectif Tryngolza 2026 à 50 M$, CA T3 +55%</news:title>
      <news:keywords>ionis-pharmaceuticals, ions-stock, tryngolza, olezarsen, dawnzera, biotech-earnings, rna-therapeutics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ionis-pharmaceuticals-q3-2026-results-tryngolza-guidance-cut</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:15:27.954Z</news:publication_date>
      <news:title>Ionis Cuts Tryngolza 2026 Sales Guide to $50M, Q3 Revenue Jumps 55%</news:title>
      <news:keywords>ionis-pharmaceuticals, ions-stock, tryngolza, olezarsen, dawnzera, biotech-earnings, rna-therapeutics</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ispire营收2750万ebitda转正</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:14:27.066Z</news:publication_date>
      <news:title>Ispire第一财季营收2750万美元，调整后EBITDA转正</news:title>
      <news:keywords>ispire-technology, ispr-stock, vaping-industry, earnings-report, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ispire-q1-ingresos-275-m-ebitda-ajustado-vuelve-a-positivo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:14:27.066Z</news:publication_date>
      <news:title>Ispire Q1 ingresos 27,5 M$, EBITDA ajustado positivo</news:title>
      <news:keywords>ispire-technology, ispr-stock, vaping-industry, earnings-report, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ispire-t1-chiffre-affaires-27-5-millions-ebitda-ajuste-positif</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:14:27.065Z</news:publication_date>
      <news:title>Ispire T1 : CA 27,5 M$, EBITDA ajusté positif</news:title>
      <news:keywords>ispire-technology, ispr-stock, vaping-industry, earnings-report, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ispire-ricavi-q1-27-5-mln-ebitda-rettificato-positivo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:14:27.065Z</news:publication_date>
      <news:title>Ispire Q1 ricavi 27,5 mln $, EBITDA rettificato positivo</news:title>
      <news:keywords>ispire-technology, ispr-stock, vaping-industry, earnings-report, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ispire-technology-q1-fiscal-2027-revenue-adjusted-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:14:27.065Z</news:publication_date>
      <news:title>Ispire Q1 Revenue $27.5M, Adjusted EBITDA Back to Positive</news:title>
      <news:keywords>ispire-technology, ispr-stock, vaping-industry, earnings-report, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/virtus第三季度eps下降30</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:13:15.413Z</news:publication_date>
      <news:title>Virtus第三季度每股收益下降30%，资产管理规模降至1414亿美元</news:title>
      <news:keywords>virtus-investment-partners, vrt-s, asset-management-earnings, net-outflows, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/virtus-eps-q3-calo-30percento-aum-141-miliardi-flussi-uscita</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:13:15.412Z</news:publication_date>
      <news:title>Virtus: EPS Q3 -30%, AUM scendono a 141,4 mld $</news:title>
      <news:keywords>virtus-investment-partners, vrt-s, asset-management-earnings, net-outflows, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/virtus-q3-bpa-cae-30-aum-baja-141400-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:13:15.412Z</news:publication_date>
      <news:title>Virtus Q3: BPA cae 30% y AUM baja a 141.400M$</news:title>
      <news:keywords>virtus-investment-partners, vrt-s, asset-management-earnings, net-outflows, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/virtus-bpa-t3-baisse-30-encours-1414-milliards-sorties</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:13:15.412Z</news:publication_date>
      <news:title>Virtus : BPA T3 en baisse de 30%, encours à 141,4 Md$</news:title>
      <news:keywords>virtus-investment-partners, vrt-s, asset-management-earnings, net-outflows, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/virtus-investment-partners-q3-2026-earnings-aum-net-outflows</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:13:15.411Z</news:publication_date>
      <news:title>Virtus Q3 EPS Falls 30% as AUM Slides to $141.4B</news:title>
      <news:keywords>virtus-investment-partners, vrt-s, asset-management-earnings, net-outflows, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/gcm-grosvenor-q3-2026-净利润-股息</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:12:10.975Z</news:publication_date>
      <news:title>GCM Grosvenor 2026年第三季度：净利润跃升17%，股息维持0.12美元</news:title>
      <news:keywords>gcm-grosvenor, gcmg-stock, alternative-asset-manager, asset-management-earnings, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/gcm-grosvenor-q3-2026-beneficio-neto-sube-17-dividendo-012</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:12:10.975Z</news:publication_date>
      <news:title>GCM Grosvenor Q3 2026: beneficio neto sube 17%, dividendo en $0.12</news:title>
      <news:keywords>gcm-grosvenor, gcmg-stock, alternative-asset-manager, asset-management-earnings, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/gcm-grosvenor-q3-2026-utile-netto-17-dividendo-012</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:12:10.974Z</news:publication_date>
      <news:title>GCM Grosvenor Q3 2026: utile netto +17%, dividendo fermo a $0,12</news:title>
      <news:keywords>gcm-grosvenor, gcmg-stock, alternative-asset-manager, asset-management-earnings, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/gcm-grosvenor-t3-2026-resultat-net-hausse-dividende-stable</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:12:10.974Z</news:publication_date>
      <news:title>GCM Grosvenor T3 2026 : résultat net +17 %, dividende stable à 0,12 $</news:title>
      <news:keywords>gcm-grosvenor, gcmg-stock, alternative-asset-manager, asset-management-earnings, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/gcm-grosvenor-q3-2026-earnings-net-income-dividend-buyback</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:12:10.974Z</news:publication_date>
      <news:title>GCM Grosvenor Q3 2026: Net Income Jumps 17%, Dividend Held at $0.12</news:title>
      <news:keywords>gcm-grosvenor, gcmg-stock, alternative-asset-manager, asset-management-earnings, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/praxis现金13亿两pdufa</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:11:15.332Z</news:publication_date>
      <news:title>Praxis精准医学现金达13亿美元，两个PDUFA日期确定</news:title>
      <news:keywords>praxis-precision-medicines, prax-stock, relutrigine, ulixacaltamide, fda-pdufa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/praxis-precision-medicines-caja-1300-millones-dos-fechas-pdufa</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:11:15.332Z</news:publication_date>
      <news:title>Praxis Precision Medicines alcanza $1.3B en caja y fija dos fechas PDUFA</news:title>
      <news:keywords>praxis-precision-medicines, prax-stock, relutrigine, ulixacaltamide, fda-pdufa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/praxis-precision-medicines-liquidita-1-3-miliardi-due-date-pdufa</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:11:15.331Z</news:publication_date>
      <news:title>Praxis Precision Medicines: liquidità a 1,3 mld $, due date PDUFA</news:title>
      <news:keywords>praxis-precision-medicines, prax-stock, relutrigine, ulixacaltamide, fda-pdufa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/praxis-precision-medicines-tresorerie-1-3-md-deux-dates-pdufa</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:11:15.331Z</news:publication_date>
      <news:title>Praxis Precision Medicines : 1,3 Md$ de trésorerie, deux dates PDUFA</news:title>
      <news:keywords>praxis-precision-medicines, prax-stock, relutrigine, ulixacaltamide, fda-pdufa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/praxis-precision-medicines-q3-2026-1-3-billion-cash-pdufa-dates</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:11:15.331Z</news:publication_date>
      <news:title>Praxis Precision Medicines Cash Hits $1.3B, Two PDUFA Dates Set</news:title>
      <news:keywords>praxis-precision-medicines, prax-stock, relutrigine, ulixacaltamide, fda-pdufa</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/village-farms大麻销售创纪录</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:10:12.321Z</news:publication_date>
      <news:title>Village Farms 2026年第三季度：大麻销售额创纪录达5500万美元</news:title>
      <news:keywords>village-farms, vff, cannabis-earnings, cannabis-stocks, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/village-farms-t3-2026-cannabis-record-margen-canada</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:10:12.321Z</news:publication_date>
      <news:title>Village Farms T3 2026: ventas de cannabis récord de 55 M$</news:title>
      <news:keywords>village-farms, vff, cannabis-earnings, cannabis-stocks, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/village-farms-q3-2026-cannabis-revenue-record-55-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:10:12.320Z</news:publication_date>
      <news:title>Village Farms Q3 2026: Cannabis Sales Hit Record $55M</news:title>
      <news:keywords>village-farms, vff, cannabis-earnings, cannabis-stocks, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/village-farms-t3-2026-ventes-cannabis-record-marge-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:10:12.320Z</news:publication_date>
      <news:title>Village Farms T3 2026 : ventes de cannabis record à 55 M$</news:title>
      <news:keywords>village-farms, vff, cannabis-earnings, cannabis-stocks, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/village-farms-q3-2026-cannabis-record-margini-in-calo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:10:12.320Z</news:publication_date>
      <news:title>Village Farms Q3 2026: vendite cannabis record a 55 milioni di $</news:title>
      <news:keywords>village-farms, vff, cannabis-earnings, cannabis-stocks, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/aura生物bel-sar三期亏损</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:09:10.841Z</news:publication_date>
      <news:title>Aura Biosciences第三季度亏损扩大至3210万美元，bel-sar三期成本攀升</news:title>
      <news:keywords>aura-biosciences, bel-sar, choroidal-melanoma, clinical-stage-biotech, nasdaq-aura</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/aura-biosciences-perdita-q3-2026-costi-bel-sar-fase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:09:10.840Z</news:publication_date>
      <news:title>Aura Biosciences: perdita Q3 sale a 32,1M$ per costi bel-sar Fase 3</news:title>
      <news:keywords>aura-biosciences, bel-sar, choroidal-melanoma, clinical-stage-biotech, nasdaq-aura</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/aura-biosciences-perdidas-t3-2026-costes-bel-sar-fase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:09:10.840Z</news:publication_date>
      <news:title>Aura Biosciences amplía pérdidas del T3 a 32,1 M$ por costes de bel-sar en fase 3</news:title>
      <news:keywords>aura-biosciences, bel-sar, choroidal-melanoma, clinical-stage-biotech, nasdaq-aura</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/aura-biosciences-perte-t3-elargie-couts-bel-sar-phase-3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:09:10.840Z</news:publication_date>
      <news:title>Aura Biosciences : perte T3 élargie à 32,1 M$ sur coûts bel-sar</news:title>
      <news:keywords>aura-biosciences, bel-sar, choroidal-melanoma, clinical-stage-biotech, nasdaq-aura</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/aura-biosciences-q3-2026-loss-widens-belsar-compass-trial-cash-runway</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:09:10.839Z</news:publication_date>
      <news:title>Aura Biosciences Q3 Loss Widens to $32.1M on bel-sar Phase 3 Costs</news:title>
      <news:keywords>aura-biosciences, bel-sar, choroidal-melanoma, clinical-stage-biotech, nasdaq-aura</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/select-water-q3-ingresos-suben-28-beneficio-neto-23m</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:08:07.127Z</news:publication_date>
      <news:title>Select Water Q3: ingresos suben 28% a 412M$, beneficio neto 23M$</news:title>
      <news:keywords>select-water-solutions, wttr, water-infrastructure, permian-basin, oilfield-services</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/select-water-q3营收增28</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:08:07.127Z</news:publication_date>
      <news:title>Select Water第三季度营收跃升28%至4.12亿美元，净利润2300万美元</news:title>
      <news:keywords>select-water-solutions, wttr, water-infrastructure, permian-basin, oilfield-services</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/select-water-t3-chiffre-affaires-412-millions-resultat-net-23-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:08:07.127Z</news:publication_date>
      <news:title>Select Water T3 : chiffre d&apos;affaires +28% à 412 M$, résultat net 23 M$</news:title>
      <news:keywords>select-water-solutions, wttr, water-infrastructure, permian-basin, oilfield-services</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/select-water-ricavi-q3-2026-crescita-28-utile-23-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:08:07.127Z</news:publication_date>
      <news:title>Select Water, ricavi Q3 +28% a 412 mln $, utile 23 mln $</news:title>
      <news:keywords>select-water-solutions, wttr, water-infrastructure, permian-basin, oilfield-services</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/select-water-solutions-q3-2026-revenue-412m-adjusted-ebitda-93m</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:08:07.127Z</news:publication_date>
      <news:title>Select Water Q3 Revenue Jumps 28% to $412M, Net Income $23M</news:title>
      <news:keywords>select-water-solutions, wttr, water-infrastructure, permian-basin, oilfield-services</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ferguson-q3-2026-sales-9-billion-raises-full-year-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:01:50.077Z</news:publication_date>
      <news:title>Ferguson Lifts 2026 Guidance as Q3 Sales Hit $9.0B</news:title>
      <news:keywords>ferguson-enterprises, ferg-stock, q3-2026-earnings, flo-works-acquisition, building-products-distribution</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/弗格森ferg上调2026指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:01:50.077Z</news:publication_date>
      <news:title>弗格森上调2026年指引，第三季度销售额达90亿美元</news:title>
      <news:keywords>ferguson-enterprises, ferg-stock, q3-2026-earnings, flo-works-acquisition, building-products-distribution</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ferguson-eleva-guia-2026-ventas-t3-9000-millones-floworks</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:01:50.077Z</news:publication_date>
      <news:title>Ferguson eleva guía 2026 tras ventas de 9.000M$ en el T3</news:title>
      <news:keywords>ferguson-enterprises, ferg-stock, q3-2026-earnings, flo-works-acquisition, building-products-distribution</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ferguson-releve-previsions-2026-ventes-t3-9-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:01:50.077Z</news:publication_date>
      <news:title>Ferguson relève ses prévisions 2026, ventes T3 à 9,0 Md$</news:title>
      <news:keywords>ferguson-enterprises, ferg-stock, q3-2026-earnings, flo-works-acquisition, building-products-distribution</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ferguson-alza-guidance-2026-vendite-q3-9-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:01:50.077Z</news:publication_date>
      <news:title>Ferguson alza la guidance 2026 con vendite Q3 a 9,0 mld $</news:title>
      <news:keywords>ferguson-enterprises, ferg-stock, q3-2026-earnings, flo-works-acquisition, building-products-distribution</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/target-hospitality-ricavi-q3-2026-crescita-perdita-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:00:37.064Z</news:publication_date>
      <news:title>Target Hospitality: ricavi +30% a 129 mln, perdita in aumento</news:title>
      <news:keywords>target-hospitality, TH-stock, q3-2026-earnings, workforce-hospitality, modular-accommodations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/target-hospitality营收增30-亏损扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:00:37.064Z</news:publication_date>
      <news:title>Target Hospitality营收跃升30%至1.29亿美元，亏损扩大</news:title>
      <news:keywords>target-hospitality, TH-stock, q3-2026-earnings, workforce-hospitality, modular-accommodations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/target-hospitality-ingresos-30-129m-perdidas-ebitda-contratos</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:00:37.064Z</news:publication_date>
      <news:title>Target Hospitality eleva ingresos un 30% a 129M$, pero amplía pérdidas</news:title>
      <news:keywords>target-hospitality, TH-stock, q3-2026-earnings, workforce-hospitality, modular-accommodations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/target-hospitality-ca-en-hausse-perte-nette-creusee</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:00:37.064Z</news:publication_date>
      <news:title>Target Hospitality : chiffre d&apos;affaires +30% à 129 M$, perte creusée</news:title>
      <news:keywords>target-hospitality, TH-stock, q3-2026-earnings, workforce-hospitality, modular-accommodations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/target-hospitality-q3-2026-revenue-129m-net-loss-widens</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:00:37.063Z</news:publication_date>
      <news:title>Target Hospitality Revenue Jumps 30% to $129M, Loss Widens</news:title>
      <news:keywords>target-hospitality, TH-stock, q3-2026-earnings, workforce-hospitality, modular-accommodations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/kkr-ani-record-1600-millones-aum-supera-804000-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:59:19.674Z</news:publication_date>
      <news:title>KKR logra un ANI récord de 1.600 M$ en el 3T y su AUM supera los 804.000 M$</news:title>
      <news:keywords>kkr-q3-2026-earnings, alternative-asset-managers, fee-related-earnings, adjusted-net-income, assets-under-management</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/kkr三季度净利润创纪录</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:59:19.674Z</news:publication_date>
      <news:title>KKR第三季度调整后净利润创纪录达16亿美元，资产管理规模突破8040亿美元</news:title>
      <news:keywords>kkr-q3-2026-earnings, alternative-asset-managers, fee-related-earnings, adjusted-net-income, assets-under-management</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/kkr-ani-record-1-6-milliard-t3-aum-804-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:59:19.674Z</news:publication_date>
      <news:title>KKR publie un ANI record de 1,6 Md$ au T3, les AUM dépassent 804 Md$</news:title>
      <news:keywords>kkr-q3-2026-earnings, alternative-asset-managers, fee-related-earnings, adjusted-net-income, assets-under-management</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/kkr-q3-2026-record-adjusted-net-income-aum-804-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:59:19.673Z</news:publication_date>
      <news:title>KKR Posts Record $1.6B Q3 ANI, AUM Tops $804 Billion</news:title>
      <news:keywords>kkr-q3-2026-earnings, alternative-asset-managers, fee-related-earnings, adjusted-net-income, assets-under-management</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/kkr-ani-record-terzo-trimestre-aum-804-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:59:19.673Z</news:publication_date>
      <news:title>KKR registra un ANI record di 1,6 miliardi nel terzo trimestre, AUM oltre 804 miliardi</news:title>
      <news:keywords>kkr-q3-2026-earnings, alternative-asset-managers, fee-related-earnings, adjusted-net-income, assets-under-management</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/星座能源ceg上调2026年eps目标</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:58:23.944Z</news:publication_date>
      <news:title>Constellation第三季度每股赚5.06美元后上调2026年EPS目标</news:title>
      <news:keywords>constellation-energy, CEG, nuclear-power, earnings-guidance, power-utilities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/constellation-eleva-objetivo-bpa-2026-trimestre-5-06-dolares</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:58:23.943Z</news:publication_date>
      <news:title>Constellation eleva objetivo de BPA 2026 tras trimestre de 5,06 $</news:title>
      <news:keywords>constellation-energy, CEG, nuclear-power, earnings-guidance, power-utilities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/constellation-releve-objectif-bpa-2026-trimestre-5-06-dollars</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:58:23.943Z</news:publication_date>
      <news:title>Constellation relève son objectif de BPA 2026 après un trimestre à 5,06 $</news:title>
      <news:keywords>constellation-energy, CEG, nuclear-power, earnings-guidance, power-utilities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/constellation-alza-target-eps-2026-trimestre-5-06</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:58:23.942Z</news:publication_date>
      <news:title>Constellation alza target EPS 2026 dopo trimestre da $5,06</news:title>
      <news:keywords>constellation-energy, CEG, nuclear-power, earnings-guidance, power-utilities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/constellation-energy-q3-2026-results-raises-earnings-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:58:23.942Z</news:publication_date>
      <news:title>Constellation Lifts 2026 EPS Target After $5.06 Quarter</news:title>
      <news:keywords>constellation-energy, CEG, nuclear-power, earnings-guidance, power-utilities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nrg-energy-beneficio-t3-2026-guia-2027-venta-activos-4-mil-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:52:05.324Z</news:publication_date>
      <news:title>NRG Energy gana 561 M$ en el T3, un 269% más, y lanza guía 2027</news:title>
      <news:keywords>nrg-energy, q3-2026-earnings, 2027-guidance, ls-power-asset-sale, utility-sector</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/nrg能源q3净利飙升269</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:52:05.324Z</news:publication_date>
      <news:title>NRG能源第三季度净利润飙升269%至5.61亿美元，启动2027年业绩指引</news:title>
      <news:keywords>nrg-energy, q3-2026-earnings, 2027-guidance, ls-power-asset-sale, utility-sector</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nrg-energy-benefice-net-t3-2026-hausse-previsions-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:52:05.324Z</news:publication_date>
      <news:title>NRG Energy : bénéfice net T3 en hausse de 269% à 561 M$</news:title>
      <news:keywords>nrg-energy, q3-2026-earnings, 2027-guidance, ls-power-asset-sale, utility-sector</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nrg-energy-q3-2026-results-2027-guidance-4-billion-asset-sale</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:52:05.323Z</news:publication_date>
      <news:title>NRG Energy Q3 Net Income Jumps 269% to $561M, Initiates 2027 Guidance</news:title>
      <news:keywords>nrg-energy, q3-2026-earnings, 2027-guidance, ls-power-asset-sale, utility-sector</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nrg-energy-utile-q3-2026-guidance-2027-vendita-asset-4-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:52:05.323Z</news:publication_date>
      <news:title>NRG Energy: utile Q3 +269% a 561 mln, guidance 2027</news:title>
      <news:keywords>nrg-energy, q3-2026-earnings, 2027-guidance, ls-power-asset-sale, utility-sector</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/loandepot-q3-2026-perdida-neta-margen-54pb-hipotecas</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:50:49.517Z</news:publication_date>
      <news:title>loanDepot Q3 2026: pérdida neta sube a 29M$, margen +54pb</news:title>
      <news:keywords>loandepot, ldi-stock, mortgage-origination, home-equity-lending, non-bank-mortgage</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/loandepot第三季度净亏损扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:50:49.517Z</news:publication_date>
      <news:title>loanDepot 2026年第三季度：净亏损扩大至2900万美元，利润率跃升54个基点</news:title>
      <news:keywords>loandepot, ldi-stock, mortgage-origination, home-equity-lending, non-bank-mortgage</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/loandepot-q3-2026-net-loss-widens-margin-jumps-54bps</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:50:49.516Z</news:publication_date>
      <news:title>loanDepot Q3 2026: Net Loss Widens to $29M, Margin Jumps 54bps</news:title>
      <news:keywords>loandepot, ldi-stock, mortgage-origination, home-equity-lending, non-bank-mortgage</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/loandepot-t3-2026-perte-nette-29-millions-marge-54-pb</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:50:49.516Z</news:publication_date>
      <news:title>loanDepot T3 2026 : perte nette à 29 M$, marge +54 pb</news:title>
      <news:keywords>loandepot, ldi-stock, mortgage-origination, home-equity-lending, non-bank-mortgage</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/loandepot-q3-2026-perdita-netta-margine-home-equity</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:50:49.516Z</news:publication_date>
      <news:title>loanDepot Q3 2026: perdita netta sale a 29 mln, margine +54bps</news:title>
      <news:keywords>loandepot, ldi-stock, mortgage-origination, home-equity-lending, non-bank-mortgage</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/vivid-seats-q3-2026-gov-ebitda-debt-recapitalization</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:44:32.395Z</news:publication_date>
      <news:title>Vivid Seats Posts $624M GOV, $200M Debt Cut in Q3 2026</news:title>
      <news:keywords>vivid-seats, seat-stock, q3-2026-earnings, recapitalization, ticket-marketplace</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/vivid-seats削减2亿美元债务</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:44:32.395Z</news:publication_date>
      <news:title>Vivid Seats 2026年Q3实现GOV 6.24亿美元，削减债务2亿美元</news:title>
      <news:keywords>vivid-seats, seat-stock, q3-2026-earnings, recapitalization, ticket-marketplace</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/vivid-seats-gov-624-millones-recorte-deuda-200-millones-t3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:44:32.395Z</news:publication_date>
      <news:title>Vivid Seats registra GOV de 624 M$ y recorte de deuda de 200 M$ en el T3 2026</news:title>
      <news:keywords>vivid-seats, seat-stock, q3-2026-earnings, recapitalization, ticket-marketplace</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/vivid-seats-gov-624-m-dette-reduite-200-m-t3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:44:32.395Z</news:publication_date>
      <news:title>Vivid Seats : GOV de 624 M$ et dette réduite de 200 M$ au T3 2026</news:title>
      <news:keywords>vivid-seats, seat-stock, q3-2026-earnings, recapitalization, ticket-marketplace</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/vivid-seats-gov-624-mln-taglio-debito-200-mln-q3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:44:32.395Z</news:publication_date>
      <news:title>Vivid Seats: GOV a 624 Mln, taglio debito da 200 Mln nel Q3 2026</news:title>
      <news:keywords>vivid-seats, seat-stock, q3-2026-earnings, recapitalization, ticket-marketplace</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/sable-offshore-chiffre-affaires-t3-hausse-arret-ventes-brut</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:43:36.121Z</news:publication_date>
      <news:title>Sable Offshore : le chiffre d&apos;affaires T3 grimpe de 13 % à 154,4 M$</news:title>
      <news:keywords>sable-offshore, soc-stock, oil-gas-earnings, monterey-formation, platform-hondo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/sable-offshore-第三季度营收增长</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:43:36.121Z</news:publication_date>
      <news:title>Sable Offshore第三季度营收增长13%至1.544亿美元</news:title>
      <news:keywords>sable-offshore, soc-stock, oil-gas-earnings, monterey-formation, platform-hondo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/sable-offshore-ingresos-q3-suben-13-comprador-crudo-parado</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:43:36.121Z</news:publication_date>
      <news:title>Sable Offshore: ingresos del tercer trimestre suben un 13% hasta 154,4 M$</news:title>
      <news:keywords>sable-offshore, soc-stock, oil-gas-earnings, monterey-formation, platform-hondo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/sable-offshore-ricavi-q3-crescita-13-cessazione-vendite-greggio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:43:36.120Z</news:publication_date>
      <news:title>Sable Offshore: ricavi Q3 +13% a 154,4 mln $</news:title>
      <news:keywords>sable-offshore, soc-stock, oil-gas-earnings, monterey-formation, platform-hondo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/sable-offshore-q3-2026-revenue-rises-13-percent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:43:36.119Z</news:publication_date>
      <news:title>Sable Offshore Q3 Revenue Rises 13% to $154.4M</news:title>
      <news:keywords>sable-offshore, soc-stock, oil-gas-earnings, monterey-formation, platform-hondo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/abeona-zveaskyn-1350万</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:42:30.935Z</news:publication_date>
      <news:title>Abeona第三季度ZEVASKYN营收达1350万美元，环比增长18%</news:title>
      <news:keywords>abeona-therapeutics, zevaskyn, gene-therapy, rare-disease, nasdaq-abeo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/abeona-zevaskyn-t3-13-5-millions-hausse-18-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:42:30.934Z</news:publication_date>
      <news:title>Abeona : le chiffre d&apos;affaires ZEVASKYN du T3 atteint 13,5 M$, en hausse de 18 %</news:title>
      <news:keywords>abeona-therapeutics, zevaskyn, gene-therapy, rare-disease, nasdaq-abeo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/abeona-zevaskyn-ingresos-t3-2026-abo-801-pipe</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:42:30.934Z</news:publication_date>
      <news:title>Abeona: ingresos de ZEVASKYN en el T3 alcanzan 13,5 M$, +18% trimestral</news:title>
      <news:keywords>abeona-therapeutics, zevaskyn, gene-therapy, rare-disease, nasdaq-abeo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/abeona-ricavi-zevaskyn-q3-13-5-mln-su-18-sequenziale</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:42:30.934Z</news:publication_date>
      <news:title>Abeona, ricavi ZEVASKYN Q3 a 13,5 mln $, +18% QoQ</news:title>
      <news:keywords>abeona-therapeutics, zevaskyn, gene-therapy, rare-disease, nasdaq-abeo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/abeona-therapeutics-q3-2026-zevaskyn-revenue-13-5-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:42:30.933Z</news:publication_date>
      <news:title>Abeona Q3 ZEVASKYN Revenue Hits $13.5M, Up 18% QoQ</news:title>
      <news:keywords>abeona-therapeutics, zevaskyn, gene-therapy, rare-disease, nasdaq-abeo</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/somnigroup第三季度23-5亿</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:41:22.996Z</news:publication_date>
      <news:title>Somnigroup第三季度销售额因Leggett &amp; Platt交易达23.5亿美元</news:title>
      <news:keywords>somnigroup, SGI, leggett-platt, earnings, bedding-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/somnigroup-t3-ventes-2-35-milliards-leggett-platt</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:41:22.995Z</news:publication_date>
      <news:title>Somnigroup T3 : ventes de 2,35 Md$ grâce à Leggett &amp; Platt</news:title>
      <news:keywords>somnigroup, SGI, leggett-platt, earnings, bedding-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/somnigroup-ventas-t3-2350-millones-leggett-platt</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:41:22.995Z</news:publication_date>
      <news:title>Somnigroup logra ventas de 2.350M$ en el T3 por Leggett &amp; Platt</news:title>
      <news:keywords>somnigroup, SGI, leggett-platt, earnings, bedding-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/somnigroup-vendite-q3-235-miliardi-leggett-platt</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:41:22.995Z</news:publication_date>
      <news:title>Somnigroup: vendite Q3 a 2,35 mld $ grazie a Leggett &amp; Platt</news:title>
      <news:keywords>somnigroup, SGI, leggett-platt, earnings, bedding-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/somnigroup-q3-2026-results-leggett-platt-acquisition-eps-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:41:22.994Z</news:publication_date>
      <news:title>Somnigroup Q3 Sales Hit $2.35B on Leggett &amp; Platt Deal</news:title>
      <news:keywords>somnigroup, SGI, leggett-platt, earnings, bedding-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/kodiak-gas上调2026年ebitda指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:34:57.022Z</news:publication_date>
      <news:title>Kodiak Gas创纪录Q3后上调2026年EBITDA指引至8.6亿美元</news:title>
      <news:keywords>kodiak-gas-services, kgs, contract-compression, adjusted-ebitda, distributed-power</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/kodiak-gas-alza-guidance-ebitda-2026-860-milioni-q3-record</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:34:57.021Z</news:publication_date>
      <news:title>Kodiak Gas alza la guidance EBITDA 2026 a 860 mln $ su Q3 record</news:title>
      <news:keywords>kodiak-gas-services, kgs, contract-compression, adjusted-ebitda, distributed-power</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/kodiak-gas-eleva-guia-ebitda-2026-record-q3-margenes-energia</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:34:57.021Z</news:publication_date>
      <news:title>Kodiak Gas eleva guía EBITDA 2026 a 860 M$ tras récord en Q3</news:title>
      <news:keywords>kodiak-gas-services, kgs, contract-compression, adjusted-ebitda, distributed-power</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/kodiak-gas-releve-prevision-ebitda-2026-t3-record</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:34:57.021Z</news:publication_date>
      <news:title>Kodiak Gas relève sa prévision d&apos;EBITDA 2026 à 860 M$ après un T3 record</news:title>
      <news:keywords>kodiak-gas-services, kgs, contract-compression, adjusted-ebitda, distributed-power</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/kodiak-gas-services-q3-2026-results-raises-ebitda-guidance</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:34:57.021Z</news:publication_date>
      <news:title>Kodiak Gas Lifts 2026 EBITDA Guidance to $860M on Record Q3</news:title>
      <news:keywords>kodiak-gas-services, kgs, contract-compression, adjusted-ebitda, distributed-power</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nesr-t3-chiffre-affaires-70-9-504-7-millions-dividende</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:23:45.729Z</news:publication_date>
      <news:title>NESR T3 : chiffre d&apos;affaires +70,9% à 504,7 M$, dividende de 0,10 $</news:title>
      <news:keywords>nesr, national-energy-services-reunited, oilfield-services, q3-2026-earnings, cash-dividend</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/nesr三季度营收飙升70-9</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:23:45.729Z</news:publication_date>
      <news:title>NESR第三季度营收飙升70.9%至5.047亿美元，宣布每股0.10美元股息</news:title>
      <news:keywords>nesr, national-energy-services-reunited, oilfield-services, q3-2026-earnings, cash-dividend</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nesr-q3-ingresos-suben-709-5047m-declara-dividendo-010</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:23:45.729Z</news:publication_date>
      <news:title>NESR Q3 ingresos suben 70,9% a 504,7M$ y declara dividendo de 0,10$</news:title>
      <news:keywords>nesr, national-energy-services-reunited, oilfield-services, q3-2026-earnings, cash-dividend</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nesr-ricavi-q3-2026-crescita-dividendo-cash-flow-negativo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:23:45.728Z</news:publication_date>
      <news:title>NESR Q3 ricavi +70,9% a 504,7 mln $, dividendo 0,10 $</news:title>
      <news:keywords>nesr, national-energy-services-reunited, oilfield-services, q3-2026-earnings, cash-dividend</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nesr-q3-2026-revenue-504-7-million-10-cent-dividend</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:23:45.727Z</news:publication_date>
      <news:title>NESR Q3 Revenue Jumps 70.9% to $504.7M, Declares $0.10 Dividend</news:title>
      <news:keywords>nesr, national-energy-services-reunited, oilfield-services, q3-2026-earnings, cash-dividend</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/伯克希尔q3净利润降221亿</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:17:32.592Z</news:publication_date>
      <news:title>伯克希尔Q3净利润降至221亿美元，回购达96亿美元</news:title>
      <news:keywords>berkshire-hathaway, brk.a, brk.b, q3-2026-earnings, insurance-float, share-buybacks, operating-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/berkshire-beneficio-t3-cae-22100-millones-recompras-9600-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:17:32.590Z</news:publication_date>
      <news:title>Beneficio neto de Berkshire en el T3 cae a 22.100 M$ con recompra de 9.600 M$</news:title>
      <news:keywords>berkshire-hathaway, brk.a, brk.b, q3-2026-earnings, insurance-float, share-buybacks, operating-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/berkshire-benefice-net-t3-22-milliards-rachats-9-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:17:32.590Z</news:publication_date>
      <news:title>Bénéfice net de Berkshire au T3 : 22,1 Md$ avec 9,6 Md$ de rachats</news:title>
      <news:keywords>berkshire-hathaway, brk.a, brk.b, q3-2026-earnings, insurance-float, share-buybacks, operating-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/berkshire-utili-q3-22-miliardi-buyback-9-6-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:17:32.589Z</news:publication_date>
      <news:title>Berkshire Q3: utili netti a 22,1 mld, buyback 9,6 mld</news:title>
      <news:keywords>berkshire-hathaway, brk.a, brk.b, q3-2026-earnings, insurance-float, share-buybacks, operating-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/berkshire-hathaway-q3-2026-net-earnings-22-billion-buybacks</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:17:32.589Z</news:publication_date>
      <news:title>Berkshire Q3 Net Earnings Fall to $22.1B as Buybacks Hit $9.6B</news:title>
      <news:keywords>berkshire-hathaway, brk.a, brk.b, q3-2026-earnings, insurance-float, share-buybacks, operating-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/原油87美元美伊谈判</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:11:18.734Z</news:publication_date>
      <news:title>原油在87美元附近盘整，美伊谈判停滞，升级风险重现</news:title>
      <news:keywords>crude-oil, wti, us-iran-negotiations, strait-of-hormuz, oil-technical-analysis</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/petrolio-consolida-87-dollari-colloqui-usa-iran-bloccati-rischio-escalation</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:11:18.733Z</news:publication_date>
      <news:title>Il petrolio consolida a 87 $ mentre i colloqui USA-Iran si bloccano, torna il rischio escalation</news:title>
      <news:keywords>crude-oil, wti, us-iran-negotiations, strait-of-hormuz, oil-technical-analysis</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/petroleo-consolida-87-dolares-conversaciones-eeuu-iran-estancadas-riesgo-es</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:11:18.733Z</news:publication_date>
      <news:title>El petróleo se consolida en 87 $ mientras las conversaciones EEUU-Irán se estancan y vuelve el riesgo de escalada</news:title>
      <news:keywords>crude-oil, wti, us-iran-negotiations, strait-of-hormuz, oil-technical-analysis</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/petrole-consolidation-87-dollars-pourparlers-us-iran-stagnent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:11:18.733Z</news:publication_date>
      <news:title>Le pétrole se consolide à 87 $, les pourparlers US-Iran stagnent</news:title>
      <news:keywords>crude-oil, wti, us-iran-negotiations, strait-of-hormuz, oil-technical-analysis</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/crude-oil-consolidates-87-us-iran-talks-stall-escalation-risk</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:11:18.733Z</news:publication_date>
      <news:title>Oil Consolidates at $87 as US-Iran Talks Stall, Escalation Risk Returns</news:title>
      <news:keywords>crude-oil, wti, us-iran-negotiations, strait-of-hormuz, oil-technical-analysis</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/dole-taglia-guidance-ebitda-2026-ricavi-q3-in-crescita</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:10:10.853Z</news:publication_date>
      <news:title>Dole taglia la guidance EBITDA 2026 a 380-390 mln, ricavi Q3 +3,8%</news:title>
      <news:keywords>dole-plc, dole-q3-2026-earnings, adjusted-ebitda-guidance, fresh-produce-stocks, nyse-dole</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/都乐下调2026ebitda指引</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:10:10.853Z</news:publication_date>
      <news:title>都乐下调2026年EBITDA指引至3.8亿-3.9亿美元，Q3营收增长3.8%</news:title>
      <news:keywords>dole-plc, dole-q3-2026-earnings, adjusted-ebitda-guidance, fresh-produce-stocks, nyse-dole</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/dole-recorta-guidance-ebitda-2026-ingresos-q3-suben</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:10:10.853Z</news:publication_date>
      <news:title>Dole recorta guidance EBITDA 2026 a 380-390 M$ con ingresos Q3 +3,8%</news:title>
      <news:keywords>dole-plc, dole-q3-2026-earnings, adjusted-ebitda-guidance, fresh-produce-stocks, nyse-dole</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/dole-abaisse-prevision-ebitda-2026-ca-t3-hausse-3-8-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:10:10.853Z</news:publication_date>
      <news:title>Dole abaisse sa prévision d&apos;EBITDA 2026 à 380-390 M$ malgré un CA en hausse de 3,8%</news:title>
      <news:keywords>dole-plc, dole-q3-2026-earnings, adjusted-ebitda-guidance, fresh-produce-stocks, nyse-dole</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/dole-plc-q3-2026-earnings-ebitda-guidance-cut-revenue-growth</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:10:10.852Z</news:publication_date>
      <news:title>Dole Cuts 2026 EBITDA Guidance to $380M-$390M as Q3 Revenue Rises 3.8%</news:title>
      <news:keywords>dole-plc, dole-q3-2026-earnings, adjusted-ebitda-guidance, fresh-produce-stocks, nyse-dole</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/qxo三季报销售额增79</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:08:58.952Z</news:publication_date>
      <news:title>QXO 2026年第三季度：销售额跃升79%至49.0亿美元，净亏损收窄</news:title>
      <news:keywords>qxo-stock, qxo-q3-2026-earnings, building-products-distribution, topbuild-acquisition, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/qxo-t3-2026-ventas-suben-79-perdida-neta-se-reduce</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:08:58.952Z</news:publication_date>
      <news:title>QXO T3 2026: ventas suben 79% a 4.900 M$, pérdida neta se reduce</news:title>
      <news:keywords>qxo-stock, qxo-q3-2026-earnings, building-products-distribution, topbuild-acquisition, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/qxo-terzo-trimestre-2026-vendite-79-percento-perdita-netta</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:08:58.951Z</news:publication_date>
      <news:title>QXO Q3 2026: vendite +79% a 4,90 mld, perdita si riduce</news:title>
      <news:keywords>qxo-stock, qxo-q3-2026-earnings, building-products-distribution, topbuild-acquisition, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/qxo-t3-2026-ventes-79-pourcent-perte-nette-reduite</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:08:58.951Z</news:publication_date>
      <news:title>QXO T3 2026 : ventes +79% à 4,90 Md$, perte nette réduite</news:title>
      <news:keywords>qxo-stock, qxo-q3-2026-earnings, building-products-distribution, topbuild-acquisition, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/qxo-q3-2026-preliminary-net-sales-4-90-billion-adjusted-ebitda</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:08:58.950Z</news:publication_date>
      <news:title>QXO Q3 2026: Sales Jump 79% to $4.90B, Net Loss Narrows</news:title>
      <news:keywords>qxo-stock, qxo-q3-2026-earnings, building-products-distribution, topbuild-acquisition, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/edesa-biotech-acuerdo-japon-kyorin-paridiprubart-146-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:07:55.222Z</news:publication_date>
      <news:title>Edesa Biotech firma un acuerdo en Japón con Kyorin por 146 M$</news:title>
      <news:keywords>edesa-biotech, kyorin-pharmaceutical, paridiprubart, ards-treatment, biotech-licensing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/edesa杏林paridiprubart日本授权</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:07:55.222Z</news:publication_date>
      <news:title>Edesa Biotech与杏林制药签署1.46亿美元日本授权协议</news:title>
      <news:keywords>edesa-biotech, kyorin-pharmaceutical, paridiprubart, ards-treatment, biotech-licensing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/edesa-biotech-accord-japon-146-millions-kyorin-paridiprubart</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:07:55.222Z</news:publication_date>
      <news:title>Edesa Biotech signe un accord japonais de 146 M$ avec Kyorin</news:title>
      <news:keywords>edesa-biotech, kyorin-pharmaceutical, paridiprubart, ards-treatment, biotech-licensing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/edesa-biotech-accordo-kyorin-giappone-paridiprubart-ards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:07:55.220Z</news:publication_date>
      <news:title>Edesa Biotech firma accordo da 146 milioni con Kyorin per il Giappone</news:title>
      <news:keywords>edesa-biotech, kyorin-pharmaceutical, paridiprubart, ards-treatment, biotech-licensing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/edesa-biotech-kyorin-paridiprubart-japan-license-deal</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T11:07:55.220Z</news:publication_date>
      <news:title>Edesa Biotech Signs $146M Japan Deal With Kyorin</news:title>
      <news:keywords>edesa-biotech, kyorin-pharmaceutical, paridiprubart, ards-treatment, biotech-licensing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/chine-ipc-octobre-08-ipp-52-marges-fragiles-yuan-soft</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:05:19.154Z</news:publication_date>
      <news:title>IPC chinois d&apos;octobre attendu près de 0,8 %, IPP au-dessus de 5 %</news:title>
      <news:keywords>china-inflation, china-cpi, china-ppi, yuan, aud-usd, macro</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/中国cpi-ppi剪刀差扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:05:19.154Z</news:publication_date>
      <news:title>中国10月CPI预计接近0.8%，PPI高于5%</news:title>
      <news:keywords>china-inflation, china-cpi, china-ppi, yuan, aud-usd, macro</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ipc-china-octubre-08-ipp-encima-5-brecha-margenes-yuan</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:05:19.154Z</news:publication_date>
      <news:title>IPC de China en octubre cerca del 0,8% y IPP por encima del 5%</news:title>
      <news:keywords>china-inflation, china-cpi, china-ppi, yuan, aud-usd, macro</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cina-cpi-ottobre-0-8-ppi-5-2-margini-industria-yuan</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:05:19.154Z</news:publication_date>
      <news:title>CPI cinese di ottobre visto vicino allo 0,8%, PPI sopra il 5%</news:title>
      <news:keywords>china-inflation, china-cpi, china-ppi, yuan, aud-usd, macro</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/china-october-cpi-ppl-inflation-preview-ppi-above-5-percent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:05:19.153Z</news:publication_date>
      <news:title>China October CPI Seen Near 0.8%, PPI Above 5%</news:title>
      <news:keywords>china-inflation, china-cpi, china-ppi, yuan, aud-usd, macro</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/国务院托底12周连跌</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:04:29.488Z</news:publication_date>
      <news:title>国务院力挺股市托底，12周连跌后转向执行</news:title>
      <news:keywords>china-equities, state-council, capital-market-stabilisation, csi-300, hang-seng</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/consejo-estado-china-apoyo-bursatil-12-semanas-caidas</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:04:29.487Z</news:publication_date>
      <news:title>El Consejo de Estado de China respalda el apoyo bursátil tras 12 semanas de caídas</news:title>
      <news:keywords>china-equities, state-council, capital-market-stabilisation, csi-300, hang-seng</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/conseil-etat-chinois-soutien-marche-12-semaines-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:04:29.487Z</news:publication_date>
      <news:title>Le Conseil d&apos;État chinois soutient le marché, 12 semaines de baisse</news:title>
      <news:keywords>china-equities, state-council, capital-market-stabilisation, csi-300, hang-seng</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/consiglio-stato-cina-sostegno-azionario-calo-12-settimane</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:04:29.487Z</news:publication_date>
      <news:title>Consiglio di Stato cinese sostiene il mercato azionario, 12 settimane di calo</news:title>
      <news:keywords>china-equities, state-council, capital-market-stabilisation, csi-300, hang-seng</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/china-state-council-capital-market-stabilisation-equities</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:04:29.486Z</news:publication_date>
      <news:title>China&apos;s State Council Backs Stock Support, 12-Week Slide</news:title>
      <news:keywords>china-equities, state-council, capital-market-stabilisation, csi-300, hang-seng</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/日本央行植田通胀上行风险</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:03:46.230Z</news:publication_date>
      <news:title>日本央行植田警示能源成本推升通胀上行风险</news:title>
      <news:keywords>boj, kazuo-ueda, japan-inflation, yen, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ueda-boj-riesgos-al-alza-inflacion-costes-energeticos-yen-jgb</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:03:46.230Z</news:publication_date>
      <news:title>Ueda del BoJ señala riesgos al alza para la inflación por los costes energéticos</news:title>
      <news:keywords>boj, kazuo-ueda, japan-inflation, yen, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/boj-ueda-risques-haussiers-inflation-couts-energie</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:03:46.229Z</news:publication_date>
      <news:title>Ueda (BoJ) signale des risques haussiers sur l&apos;inflation</news:title>
      <news:keywords>boj, kazuo-ueda, japan-inflation, yen, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/boj-ueda-rischi-inflazione-rialzo-costi-energetici-yen-jgb</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:03:46.229Z</news:publication_date>
      <news:title>Ueda (BOJ) segnala rischi al rialzo sull&apos;inflazione, pesano i costi energetici</news:title>
      <news:keywords>boj, kazuo-ueda, japan-inflation, yen, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/boj-ueda-upside-inflation-risks-energy-costs-yen-jgb-yields</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:03:46.229Z</news:publication_date>
      <news:title>BOJ&apos;s Ueda Flags Upside Inflation Risks as Energy Costs Bite</news:title>
      <news:keywords>boj, kazuo-ueda, japan-inflation, yen, jgb-yields</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/特朗普apec会晤英伟达跌6-74</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:02:55.600Z</news:publication_date>
      <news:title>特朗普拟在APEC会晤习近平与普京，英伟达下跌6.74%</news:title>
      <news:keywords>trump-xi-putin-meeting, apec-summit-2026, nvidia-huang-china, iran-war-oil, nvidia-stock-fall</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/trump-xi-putin-apec-nvidia-calo-674-huang</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:02:55.598Z</news:publication_date>
      <news:title>Trump punta a Xi e Putin all&apos;APEC, Nvidia giù del 6,74%</news:title>
      <news:keywords>trump-xi-putin-meeting, apec-summit-2026, nvidia-huang-china, iran-war-oil, nvidia-stock-fall</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/trump-xi-putin-apec-nvidia-cae-huang-investigacion-china</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:02:55.598Z</news:publication_date>
      <news:title>Trump busca a Xi y Putin en APEC mientras Nvidia cae 6,74%</news:title>
      <news:keywords>trump-xi-putin-meeting, apec-summit-2026, nvidia-huang-china, iran-war-oil, nvidia-stock-fall</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/trump-xi-poutine-apec-nvidia-chute-6-74-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:02:55.598Z</news:publication_date>
      <news:title>Trump vise Xi et Poutine à l&apos;APEC, Nvidia chute de 6,74 %</news:title>
      <news:keywords>trump-xi-putin-meeting, apec-summit-2026, nvidia-huang-china, iran-war-oil, nvidia-stock-fall</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/trump-xi-putin-apec-meeting-nvidia-huang-fall-iran-war-oil</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T00:02:55.598Z</news:publication_date>
      <news:title>Trump Eyes Xi and Putin at APEC as Nvidia Falls 6.74%</news:title>
      <news:keywords>trump-xi-putin-meeting, apec-summit-2026, nvidia-huang-china, iran-war-oil, nvidia-stock-fall</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/bitcoin-sotto-74600-nvidia-testa-appetito-rischio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:11:16.986Z</news:publication_date>
      <news:title>Bitcoin scivola sotto 74.600$ mentre Nvidia mette alla prova il rischio</news:title>
      <news:keywords>bitcoin, nvidia, crypto-markets, risk-appetite, bitcoin-etf-outflows</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/比特币英伟达74-600美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:11:16.986Z</news:publication_date>
      <news:title>比特币跌破74,600美元，英伟达下挫考验风险偏好</news:title>
      <news:keywords>bitcoin, nvidia, crypto-markets, risk-appetite, bitcoin-etf-outflows</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/bitcoin-cae-bajo-74600-nvidia-prueba-apetito-riesgo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:11:16.986Z</news:publication_date>
      <news:title>Bitcoin cae bajo 74.600 $ mientras Nvidia pone a prueba el apetito de riesgo</news:title>
      <news:keywords>bitcoin, nvidia, crypto-markets, risk-appetite, bitcoin-etf-outflows</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/bitcoin-sous-74600-nvidia-teste-appetit-pour-le-risque</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:11:16.986Z</news:publication_date>
      <news:title>Bitcoin sous 74 600 $, Nvidia teste l&apos;appétit pour le risque</news:title>
      <news:keywords>bitcoin, nvidia, crypto-markets, risk-appetite, bitcoin-etf-outflows</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/bitcoin-slips-under-74600-nvidia-slide-tests-risk-appetite</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:11:16.984Z</news:publication_date>
      <news:title>Bitcoin Slips Under $74,600 as Nvidia Slide Tests Risk Appetite</news:title>
      <news:keywords>bitcoin, nvidia, crypto-markets, risk-appetite, bitcoin-etf-outflows</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/卢比奥伊朗谈判石油溢价</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:10:24.964Z</news:publication_date>
      <news:title>卢比奥称伊朗谈判无进展，石油战争风险溢价走强</news:title>
      <news:keywords>iran-talks, rubio-iran, oil-war-risk-premium, strait-of-hormuz, khor-mor-gas-field</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/rubio-iran-conversaciones-no-productivas-premio-riesgo-belico-crudo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:10:24.964Z</news:publication_date>
      <news:title>Rubio dice que las conversaciones con Irán no son productivas y el premio de riesgo bélico del crudo se afianza</news:title>
      <news:keywords>iran-talks, rubio-iran, oil-war-risk-premium, strait-of-hormuz, khor-mor-gas-field</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/rubio-colloqui-iran-non-produttivi-premio-rischio-guerra-petrolio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:10:24.963Z</news:publication_date>
      <news:title>Rubio: colloqui Iran non produttivi, premio rischio guerra sul petrolio</news:title>
      <news:keywords>iran-talks, rubio-iran, oil-war-risk-premium, strait-of-hormuz, khor-mor-gas-field</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/rubio-pourparlers-iran-non-productifs-prime-risque-guerre-petrole</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:10:24.963Z</news:publication_date>
      <news:title>Rubio : les pourparlers avec l&apos;Iran ne sont pas productifs, la prime de risque de guerre se raffermit</news:title>
      <news:keywords>iran-talks, rubio-iran, oil-war-risk-premium, strait-of-hormuz, khor-mor-gas-field</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/rubio-iran-talks-not-productive-oil-war-risk-premium</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:10:24.962Z</news:publication_date>
      <news:title>Rubio Says Iran Talks Not Productive, Oil War-Risk Premium Firms</news:title>
      <news:keywords>iran-talks, rubio-iran, oil-war-risk-premium, strait-of-hormuz, khor-mor-gas-field</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/英伟达nvda间谍调查181美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:09:32.107Z</news:publication_date>
      <news:title>英伟达董事会调查间谍指控，NVDA守住186.64美元：181美元成关键</news:title>
      <news:keywords>nvidia, nvda-stock, jensen-huang, semiconductor-stocks, spy-allegations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nvda-mantiene-186-64-consejo-investiga-espionaje-181-clave</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:09:32.107Z</news:publication_date>
      <news:title>NVDA mantiene 186,64 $ mientras el consejo investiga acusaciones de espionaje: 181 $ clave</news:title>
      <news:keywords>nvidia, nvda-stock, jensen-huang, semiconductor-stocks, spy-allegations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nvda-board-indaga-spionaggio-181-chiave</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:09:32.106Z</news:publication_date>
      <news:title>NVDA tiene $186,64 mentre il board indaga su spionaggio: $181 chiave</news:title>
      <news:keywords>nvidia, nvda-stock, jensen-huang, semiconductor-stocks, spy-allegations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nvda-tient-186-64-le-conseil-enquete-sur-les-allegations-d-espionnage</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:09:32.106Z</news:publication_date>
      <news:title>NVDA tient 186,64 $, le conseil enquête : 181 $ clé</news:title>
      <news:keywords>nvidia, nvda-stock, jensen-huang, semiconductor-stocks, spy-allegations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nvda-stock-board-spy-investigation-181-172-164-levels</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:09:32.105Z</news:publication_date>
      <news:title>NVDA Holds $186.64 as Board Probes Spy Claims: $181 Key</news:title>
      <news:keywords>nvidia, nvda-stock, jensen-huang, semiconductor-stocks, spy-allegations</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/rba-hunter-advierte-riesgo-reprrecio-activos-ia-tasa-efectivo-485</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:08:41.941Z</news:publication_date>
      <news:title>Hunter del RBA advierte riesgo de reprrecio de activos por IA, tasa de efectivo en 4,85%</news:title>
      <news:keywords>rba, sarah-hunter, ai-inflation, aud, australian-interest-rates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/澳联储ai重定价4-85</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:08:41.941Z</news:publication_date>
      <news:title>澳洲联储亨特警告AI资产重定价风险，现金利率维持4.85%</news:title>
      <news:keywords>rba, sarah-hunter, ai-inflation, aud, australian-interest-rates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/rba-hunter-risque-revalorisation-actifs-ia-taux-485</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:08:41.941Z</news:publication_date>
      <news:title>La RBA avertit d&apos;un risque de revalorisation des actifs liés à l&apos;IA, taux à 4,85%</news:title>
      <news:keywords>rba, sarah-hunter, ai-inflation, aud, australian-interest-rates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/rba-hunter-rischio-repricing-asset-ai-tasso-4-85</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:08:41.940Z</news:publication_date>
      <news:title>La RBA avverte: Hunter segnala rischio di repricing AI, tasso al 4,85%</news:title>
      <news:keywords>rba, sarah-hunter, ai-inflation, aud, australian-interest-rates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/rba-hunter-ai-asset-repricing-inflation-cash-rate-4-85</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:08:41.940Z</news:publication_date>
      <news:title>RBA&apos;s Hunter Warns AI Asset Repricing Risk, Cash Rate at 4.85%</news:title>
      <news:keywords>rba, sarah-hunter, ai-inflation, aud, australian-interest-rates</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/胡塞袭阿美红海油险</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:07:46.751Z</news:publication_date>
      <news:title>胡塞武装袭击利雅得阿美大厦，红海石油风险上升</news:title>
      <news:keywords>houthi-aramco-tower-strike, saudi-arabia-oil-supply-risk, red-sea-tanker-attacks, war-risk-premium-crude, strait-of-hormuz-disruption</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/huties-torre-aramco-riad-riesgo-petroleo-mar-rojo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:07:46.751Z</news:publication_date>
      <news:title>Hutíes golpean la Torre Aramco en Riad y sube el riesgo petrolero del mar Rojo</news:title>
      <news:keywords>houthi-aramco-tower-strike, saudi-arabia-oil-supply-risk, red-sea-tanker-attacks, war-risk-premium-crude, strait-of-hormuz-disruption</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/houthis-frappent-aramco-tower-riyad-risque-mer-rouge</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:07:46.750Z</news:publication_date>
      <news:title>Les Houthis frappent l&apos;Aramco Tower à Riyad, le risque mer Rouge monte</news:title>
      <news:keywords>houthi-aramco-tower-strike, saudi-arabia-oil-supply-risk, red-sea-tanker-attacks, war-risk-premium-crude, strait-of-hormuz-disruption</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/houthi-colpiscono-aramco-tower-riad-rischio-petrolio-mar-rosso</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:07:46.750Z</news:publication_date>
      <news:title>Houthi colpiscono Aramco Tower a Riad, sale il rischio petrolio nel Mar Rosso</news:title>
      <news:keywords>houthi-aramco-tower-strike, saudi-arabia-oil-supply-risk, red-sea-tanker-attacks, war-risk-premium-crude, strait-of-hormuz-disruption</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/houthis-strike-aramco-tower-riyadh-red-sea-oil-supply-risk</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:07:46.749Z</news:publication_date>
      <news:title>Houthis Hit Aramco Tower in Riyadh as Red Sea Oil Risk Rises</news:title>
      <news:keywords>houthi-aramco-tower-strike, saudi-arabia-oil-supply-risk, red-sea-tanker-attacks, war-risk-premium-crude, strait-of-hormuz-disruption</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/布卢门撒尔币安tether记录截止</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:06:47.091Z</news:publication_date>
      <news:title>布卢门撒尔设定1月4日为币安、Tether记录截止日</news:title>
      <news:keywords>blumenthal-crypto-investigation, binance-tether-records, world-liberty-financial, trump-memecoin, crypto-market-structure-bill</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/blumenthal-termine-4-gennaio-binance-tether-registri</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:06:47.090Z</news:publication_date>
      <news:title>Blumenthal fissa al 4 gennaio il termine per Binance e Tether</news:title>
      <news:keywords>blumenthal-crypto-investigation, binance-tether-records, world-liberty-financial, trump-memecoin, crypto-market-structure-bill</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/blumenthal-plazo-4-enero-registros-binance-tether</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:06:47.090Z</news:publication_date>
      <news:title>Blumenthal fija el 4 de enero como plazo para los registros de Binance y Tether</news:title>
      <news:keywords>blumenthal-crypto-investigation, binance-tether-records, world-liberty-financial, trump-memecoin, crypto-market-structure-bill</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/blumenthal-date-limite-4-janvier-binance-tether-dossiers</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:06:47.090Z</news:publication_date>
      <news:title>Blumenthal fixe au 4 janvier la date limite pour Binance et Tether</news:title>
      <news:keywords>blumenthal-crypto-investigation, binance-tether-records, world-liberty-financial, trump-memecoin, crypto-market-structure-bill</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/blumenthal-jan-4-deadline-binance-tether-trump-crypto-records</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T23:06:47.090Z</news:publication_date>
      <news:title>Blumenthal Sets Jan 4 Deadline for Binance, Tether Records</news:title>
      <news:keywords>blumenthal-crypto-investigation, binance-tether-records, world-liberty-financial, trump-memecoin, crypto-market-structure-bill</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/英伟达黄仁勋调查跌6-74</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:08:48.154Z</news:publication_date>
      <news:title>英伟达因黄仁勋绯闻调查下跌6.74%</news:title>
      <news:keywords>nvidia, jensen-huang, nvda-stock, china-export-controls, ai-chips</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nvidia-cae-674-investigacion-huang-consejo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:08:48.154Z</news:publication_date>
      <news:title>Nvidia cae 6,74% por investigación sobre Huang</news:title>
      <news:keywords>nvidia, jensen-huang, nvda-stock, china-export-controls, ai-chips</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nvidia-calo-6-74-caso-huang-indagine-consiglio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:08:48.153Z</news:publication_date>
      <news:title>Nvidia scivola del 6,74%: il caso Huang colpisce le azioni</news:title>
      <news:keywords>nvidia, jensen-huang, nvda-stock, china-export-controls, ai-chips</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nvidia-chute-674-procedure-huang-affaire-conseil</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:08:48.153Z</news:publication_date>
      <news:title>Nvidia chute de 6,74 %, la procédure Huang pèse sur le titre</news:title>
      <news:keywords>nvidia, jensen-huang, nvda-stock, china-export-controls, ai-chips</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nvidia-shares-fall-huang-affair-china-spy-board-investigation</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:08:48.152Z</news:publication_date>
      <news:title>Nvidia Slides 6.74% as Huang Affair Probe Hits Shares</news:title>
      <news:keywords>nvidia, jensen-huang, nvda-stock, china-export-controls, ai-chips</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/特朗普伊朗打击三航母待命</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:58.256Z</news:publication_date>
      <news:title>特朗普称伊朗打击&quot;极不可能&quot; 但三艘航母仍待命</news:title>
      <news:keywords>iran-ceasefire-talks, strait-of-hormuz, oil-war-risk-premium, trump-iran-strikes, nvda-shares</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/trump-iran-muy-improbable-tres-portaaviones-petroleo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:58.256Z</news:publication_date>
      <news:title>Trump ve &quot;muy improbable&quot; atacar Irán pero mantiene tres portaaviones</news:title>
      <news:keywords>iran-ceasefire-talks, strait-of-hormuz, oil-war-risk-premium, trump-iran-strikes, nvda-shares</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/trump-attacchi-iran-molto-improbabili-tre-portaerei-pronte-petrolio</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:58.255Z</news:publication_date>
      <news:title>Trump: attacchi all&apos;Iran &quot;molto improbabili&quot;, ma tre portaerei restano pronte</news:title>
      <news:keywords>iran-ceasefire-talks, strait-of-hormuz, oil-war-risk-premium, trump-iran-strikes, nvda-shares</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/trump-frappes-iran-tres-improbables-trois-porte-avions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:58.255Z</news:publication_date>
      <news:title>Trump juge les frappes sur l&apos;Iran « très improbables » mais garde trois porte-avions</news:title>
      <news:keywords>iran-ceasefire-talks, strait-of-hormuz, oil-war-risk-premium, trump-iran-strikes, nvda-shares</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/trump-iran-strikes-highly-unlikely-three-carriers-hormuz-talks</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:58.255Z</news:publication_date>
      <news:title>Trump Sees Iran Strikes &quot;Highly Unlikely&quot; But Keeps Three Carriers Ready</news:title>
      <news:keywords>iran-ceasefire-talks, strait-of-hormuz, oil-war-risk-premium, trump-iran-strikes, nvda-shares</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/霍尔莫尔无人机袭击库尔德断电</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:07.954Z</news:publication_date>
      <news:title>霍尔莫尔无人机袭击致库尔德斯坦断电2.8吉瓦</news:title>
      <news:keywords>khor-mor-gas-field, kurdistan-power-outage, iran-drone-strike, oil-war-risk-premium, iraq-energy-infrastructure</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ataque-dron-khor-mor-recorta-energia-kurdistan-irak</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:07.954Z</news:publication_date>
      <news:title>Ataque con dron en Khor Mor recorta 2,8 GW de energía en Kurdistán</news:title>
      <news:keywords>khor-mor-gas-field, kurdistan-power-outage, iran-drone-strike, oil-war-risk-premium, iraq-energy-infrastructure</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/attacco-drone-khor-mor-taglia-28gw-energia-kurdistan</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:07.953Z</news:publication_date>
      <news:title>Attacco drone a Khor Mor taglia 2,8GW in Kurdistan</news:title>
      <news:keywords>khor-mor-gas-field, kurdistan-power-outage, iran-drone-strike, oil-war-risk-premium, iraq-energy-infrastructure</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/frappe-drone-khor-mor-coupe-28-gw-electricite-kurdistan</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:07.953Z</news:publication_date>
      <news:title>Frappe de drone à Khor Mor coupe 2,8 GW au Kurdistan</news:title>
      <news:keywords>khor-mor-gas-field, kurdistan-power-outage, iran-drone-strike, oil-war-risk-premium, iraq-energy-infrastructure</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/khor-mor-drone-strike-cuts-kurdistan-power-iran-war-risk-premium</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:07:07.952Z</news:publication_date>
      <news:title>Khor Mor Drone Strike Cuts 2.8GW Kurdistan Power</news:title>
      <news:keywords>khor-mor-gas-field, kurdistan-power-outage, iran-drone-strike, oil-war-risk-premium, iraq-energy-infrastructure</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/新西兰大选纽元nzd</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:06:15.825Z</news:publication_date>
      <news:title>新西兰大选悬而未决，纽元微涨0.5%</news:title>
      <news:keywords>nzd-usd, new-zealand-election, christopher-luxon, nicola-willis, rbnz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nzd-sube-elecciones-nueva-zelanda-limbo-politico</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:06:15.825Z</news:publication_date>
      <news:title>El NZD sube un 0,5% mientras Nueva Zelanda afronta semanas de limbo político</news:title>
      <news:keywords>nzd-usd, new-zealand-election, christopher-luxon, nicola-willis, rbnz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nzd-sale-nuova-zelanda-stallo-politico-elezioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:06:15.824Z</news:publication_date>
      <news:title>NZD sale dello 0,5%, Nuova Zelanda verso settimane di stallo politico</news:title>
      <news:keywords>nzd-usd, new-zealand-election, christopher-luxon, nicola-willis, rbnz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nzd-firms-new-zealand-election-political-limbo-coalition-talks</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:06:15.824Z</news:publication_date>
      <news:title>NZD Firms 0.5% as New Zealand Faces Weeks of Political Limbo</news:title>
      <news:keywords>nzd-usd, new-zealand-election, christopher-luxon, nicola-willis, rbnz</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nzd-gagne-0-5-nouvelle-zelande-semaines-limbo-politique</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-08T22:06:15.824Z</news:publication_date>
      <news:title>Le NZD gagne 0,5 %, la Nouvelle-Zélande face à des semaines de limbo politique</news:title>
      <news:keywords>nzd-usd, new-zealand-election, christopher-luxon, nicola-willis, rbnz</news:keywords>
    </news:news>
  </url>
</urlset>